Government Buyers Guide for Healthcare - April 2015

Government Buyers Guide
for Healthcare
April 2015
Visit Us Online At www.govhealthcare.com

Proudly supports all of your dental, medical, and supply needs.
Supporting your supply needs through the following contracts:
NEW! DLA ECAT Dental Program SPM2DE-14-D-7469
DLA ECAT Lab Contract SPM2DE-10-D-7342
DLA Medical/Surgical DAPA Holder SP0200-96-H-5014
FEDERAL SUPPLY SCHEDULES:
Pharmaceuticals and Drugs (Anesthetics) V797P-2280D
Dental Equipment and Supplies V797P-3160M
HENRY SCHEIN, INC. IS A PROUD
FEDERAL SUPPLY SCHEDULE DISTRIBUTOR FOR:
Welch Allyn—Medical Equipment and Supplies V797P-4333B
Brewer Design Medical Equipment and Supplies V797P-3206M
KaVo Dental Equipment V797P-3218M
GYN Disposables V797P-4377B
Kerr V797D-30021
Imaging Sciences Dental Equipment V797P-3235M
Pelton & Crane Contract V797P-3241M
Busse Hospital Disposables—Medical Equipment
and Supplies V797P-4488B

Government Health Care Publication
The Government Health Care Buyers Guide for
the United States is a quarterly publication that
provides relevant, up-to-date information on the
nation’s health care industry. This magazine
covers every relevant topic: from legislation
proposals to advancements in medical research,
from policy updates to contract awards, from
FDA news to information on industrial and
government health care events.
Please call our corporate office at (805) 845-4921
for inquiries, comments, and suggestions.
Inside this Guide
Stay Up-to-Date on
Government Health Care News
Proposals & Changes to Health Care Laws
New Advancements in Medical Research
Product Releases and FDA Approvals
Health Industry Contracting Awards
Event Info for Industry & Government
Federal Buyers Guide, Inc.
Chief Executive Officer
Stuart Miller
Vice President of Operations
Afzal Hussain
Editor-in-Chief
Alejandra Saragoza
IT Department
Shawn Whitney
Sales & Marketing Manager
John Jenkins
Account Representatives
Jeff Stakee
Johan Delsol
Scott Maio
Accounting Department
Stephanie Arellanes
Production Staff
Andrew Tuttle
Jerry Fair
Reach Us At:
www.govsupplier.com
Email: info@fbgglobal.com
Federal Buyers Guide, Inc.
324 Palm Avenue
Santa Barbara, CA 93101
Tel: (805) 963-7470
Fax: (805) 963-7478
Copyright © 2014 by Federal Buyers Guide, Inc. All rights reserved. No parts of this publication
may be reproduced or transmitted in any form, electronic or mechanical, including photocopying,
recording, or any information storage retrieval system, without written permission of the copyright
owner.

Don’t get
trapped in
a box...
...we have
the perfect
mailbox
solution.
Whether your housing project needs mailboxes
for two or two-thousand residents, Florence has
the most extensive selection in the industry. Don’t
get trapped with limited options, let our dedicated
team partner with you to develop a custom solution
built on your needs. . .not what is in stock.
centralized mailboxes since 1934. Let us help take
your centralized mail delivery concept from the
drawing board to reality, providing you with the
perfect mailbox solution.
Design and construction professionals have relied
upon the secure, first-class design of Florence’s
Call Florence Today Toll-free
800.275.1747
Proud to Say Our Products Are
Made in America
Visit Us Online For More Info
florencemailboxes.com

Table of Contents
nEWS
Siemens Introduces Smart Hearing Aids.............................................................................................................................9
Lockheed Martin and Illumina to Collaborate on Developing Genomics Solutions to Improve
Public Health and Wellness................................................................................................................................................11
Healthcare Industry Optimistic Despite Challenges, Says New GE Capital Survey......................................................13
FDA Approves First-of-Kind Device to Treat Obesity......................................................................................................15
Progress Being Made in Infection Control in U.S. Hospitals; Continued Improvements Needed........................17
UTC Donates $1.5 Million to Create New Family Resource Center at Connecticut Children’s
Medical Center...................................................................................................................................................................19
Better, Smarter, Healthier: In Historic Announcement, HHS Sets Clear Goals and Timeline for
Shifting Medicare Reimbursementsfrom Volume to Value.........................................................................................21
HHS Proposes Path to Improve HealthTechnology and Transform Care.................................................................23
Cerner Completes Acquisition of Siemens Health Services.......................................................................................................... 25
Kallo Selects IBM Cloud Technology to Help Transform Health Care in Remote Communities..........................27
St. Jude Medical Launches U.S. Study of the Country’s Smallest Pediatric Mechanical Heart Valve...................29
New Affordable Care Act Initiative to Encourage Better Oncology Care.................................................................33
Cerner, Mortara Introduce CareAware Waveform Management.....................................................................................35
NIH-Funded Scientists Create Potential Long- Acting HIV Therapeutic..................................................................37
Booz Allen Hamilton Partners with HITRUST on Series of Cyber Preparedness and Education
Town Halls for Healthcare Industry...................................................................................................................................39
Surescripts Leverages Technology to Help Doctors Address Prescription Fraud and Abuse.........................................41
HHS Invests in Enhancing Domestic Preparedness Efforts for Ebola...............................................................................43
3D Systems Debuts Powerful New All-In-One Medical 3D Printer at LMT LAB DAY Chicago.....................................45
New Data from CCN Demonstrate Potential of CT to Transform the Cardiac Care Pathway........................................47
Northeastern University Researchers Find Inhaling Supplemental Oxygen Can Awaken Anti-Tumor Cells................49
Saving Precious Time: Siemens’ New Ultrasound System for Faster Imaging.................................................................51
GE Ventures and Stanford Health Care Launch Digital Health Company.......................................................................53
FDA Approves First Biosimilar Product Zarxio.................................................................................................................55
Concordia Healthcare Corp. to Acquire Covis Pharma Commercial Assets for $1.2 Billion...........................................57
Apple Introduces ResearchKit, Giving Medical Researchers the Tools to Revolutionize Medical Studies.....................59
FDA Approves CPR Devices That May Increase Chance of Surviving Cardiac Arrest....................................................61
Events & TRADE SHoWS
Centers for Medicare and Medicaid Services (CMS) CISO Security & Privacy Forum....................................................63
HIMSS15 Annual Conference & Exhibition........................................................................................................................65
2015 Preparedness Summit..................................................................................................................................................67
Military and Government Electronic Health Records & Health Data Interoperability Symposium...............................69
VA Healthcare Summit 2015................................................................................................................................................71
2015 ASCO Annual Meeting................................................................................................................................................73
Travel Guide for Business Professionals
Chicago, Illinois...................................................................................................................................................................75

PROTECTING
THOSE WHO PROTECT US
MADE IN THE
USA
I375NAV
Stearns® Inflata-Belt
Max - Manual
I446
Stearns® U.S. Navy MK-1
Inflatable vest
I
I
II ®
I
I077
Stearns® Powerboat Jacket
I580
Stearns® Coreguard
B Anti-Exposure Coverall
Contact: Riika Jorgensen
National Account Manager-Government
riika.jorgensen@coleman.com I 757.675.9367
®

A Trusted Source to All Major
U.S. Defense, Intelligence,
and Civilian Agencies
IT Infrastructure
• Cabinets & Racks
• Cabling & Panels
• Power & Cooling
• Testers & Tools
• Remote Monitoring
High-Performance KVM
• Desktop KVM Switches
• KVM Extenders
• KVM Matrix Switches
• KVM-over-IP
• Secure KVM
Specialty Networking
• WAN Encryption
• Ethernet Switches & Extenders
• Media Converters
• Power-over-Ethernet
• Hardened Devices
AV & Digital Signage
• AV-over-IP
• Switches & Extenders
• Scalers & Converters
• Splitters & Cables
• Digital Signage Systems
Request a catalog: blackbox.com/FBG11
GSA Schedule 70, Contract #GS-35F-0158J.
Cage Code 59951, DUNS# 082254871, Federal ID# 25-1272662.
Black Box accepts all government purchasing cards.
724-746-5500 | blackbox.com

News
Siemens Introduces Smart Hearing Aids
January 5, 2015
At the 2015 International CES, Siemens is unveiling
smart hearing aids—their latest in wearable hearing
technology. The hearing aids can be discreetly
controlled via both iPhone® and Android devices,
with latest models clinically proven to outperform
people with normal hearing in background noise.
When two hearing aids are worn (the most common
case), Siemens’ new smart hearing aids utilize intelligent, two-way wireless communication to
zero in on desired speech with pinpoint accuracy. This enables better-than-normal hearing in
crowded situations like noisy restaurants and cocktail parties where background chatter has
historically been a challenge.
“These are not your average hearing aids but rather highly-intelligent wearable devices,” said
Scott Davis, CEO Siemens Hearing Instruments. “They automatically detect everyday listening
environments such as a noisy room, wind, or while driving a car, and instinctively know what to
do.”
When paired with Siemens’ new easyTek and easyTek App, a wearer can control the
direction of the hearing aids’ microphones—front, left, right, or behind—to simultaneously
enhance speech and suppress background noise. The span of the microphones’ focus can also be
controlled via the app, allowing wearers to select a wide range of focus or a very narrow beam.
“Some hearing aid wearers also want the flexibility that comes with having control over their
listening experience,” added Davis. “We’ve all heard of and can appreciate the benefits of ondemand
TV. With these hearing aids, you can turn your iPhone or Android device into a hearing
aid control center. We call it on-demand hearing.”
While Siemens’ new smart hearing aids pair with virtually any iOS or Android mobile device for
a custom-tailored listening experience, a smartphone is not required to make use of the new
technology. The hearing aids continuously scan the acoustic environment and activate the most
optimal settings for that particular listening situation. For example, if you’re at a noisy family
gathering, the smart hearing aids hone in on speech coming from the front while softening
speech and noise from other directions. Later, if you’re out walking the dog, they automatically
adjust so you can enjoy the sounds of nature.
Because both hearing aids are in constant communication and processing sound simultaneously,
this creates a high-definition surround sound listening experience, with no manual adjustments
required.

News
Lockheed Martin and Illumina to Collaborate on
Developing Genomics Solutions to Improve
Public Health and Wellness
January 12, 2015
ROCKVILLE, MD & SAN DIEGO, CA -- Lockheed Martin
and Illumina, Inc. today announced a new strategic alliance to
collaborate on scalable and affordable genomics solutions to
provide personalized health care for national populations.
Genomics is the science of studying genomes or DNA.
Applied to health care, analyzing a person’s DNA sequence
data can provide a better understanding of health risks (such as
how susceptible a person is to a particular disease or the
person may react to a type of medication), resulting in more precise and proactive medicine. By
aggregating genomic data across large populations, public health and wellness officials can more
effectively address health concerns, reducing health care costs and improving quality of life.
The alliance brings together Illumina’s next-generation genetic sequencing tools with Lockheed
Martin’s expertise in large-scale information systems and integration to meet the needs of
countries as they begin to integrate genomics into their national health systems.
“Genomics is enabling a fundamental transformation of health care,” said Horace Blackman,
vice president of Health & Life Sciences for Lockheed Martin’s Information Systems & Global
Solutions business. “We envision the advantages of early national adoption for countries across
the globe, applying clinical decision support applications that can improve health and health
care, and lower national health care costs.”
“We look forward to working with Lockheed Martin and global health care leaders as we
develop best-in-class solutions to realize the full potential of nation-scale sequencing,” said Jay
Flatley, Chief Executive Officer of Illumina. “We are excited about this collaboration, given the
breadth and depth of Lockheed Martin’s operations and strategic relationships around the globe.”

News
Healthcare Industry Optimistic Despite
Challenges, Says New GE Capital Survey
January 13, 2015
BETHESDA, MD -- While they acknowledge the
challenges facing them, healthcare industry leaders
in the U.S. are less concerned about healthcare
reform and regulatory oversight than they were
one year ago, according to a survey conducted by
GE Capital’s Healthcare Financial Services
business. Overall, they’re optimistic about the
future and are relying on a combination of mergers
and acquisitions and organic growth to expand.
Forty-three percent of respondents said implementing the Affordable Care Act (ACA) is the
greatest challenge facing the healthcare industry in 2015. The second-greatest challenge cited
was regulatory oversight, selected by 30 percent. The U.S. economy came in third at 17 percent.
Last year, 57 percent of respondents to a similar GE Capital survey said that ACA
implementation was their greatest challenge, followed by regulatory oversight (20 percent) and
the U.S. economy (13 percent).
More than two-thirds (68 percent) of respondents said they expect their business to perform more
strongly in 2015 than in 2014. Less than one-third (29 percent) said that it would perform the
same and only three percent said that it would be weaker this year.
“We agree with the optimism shown by our customers and other healthcare industry leaders
about 2015. Though less than last year, implementation of the ACA is still top of mind across the
industry,” said Al Aria, senior managing director of GE Capital, Healthcare Financial Services’
corporate finance team. “We look forward to supporting customers as they adapt and grow
amidst the changing healthcare landscape.”
GE Capital conducted the survey shortly before the large gathering of healthcare professionals in
San Francisco (which coincides with J.P. Morgan’s Annual Healthcare Conference, which is
being held Jan. 12-15). Respondents were asked about their industry and company outlook for
2015. They included 521 senior executives from healthcare companies representing
pharmaceuticals, healthcare IT and medical technology companies, hospitals, healthcare service
providers and health systems, as well as other industry participants.

Security & Border Control
Power, Energy & Oil Field Services
Engineering & Construction
Shipping & Logistics
Travel & Visas
Telecom Services
Software
GROUP
Your reliable partner in the Middle East and Africa
GROUP
Griffin Ltd. is an International group of companies with operations
since 1997 throughout the Middle East and Africa.
GriffinGroup.com

FDA Approves First-of-Kind Device to Treat
Obesity
News
January 14, 2015
The U.S. Food and Drug Administration today
approved the Maestro Rechargeable System for
certain obese adults, the first weight loss treatment
device that targets the nerve pathway between the
brain and the stomach that controls feelings of
hunger and fullness. The Maestro Rechargeable
System, the first FDA-approved obesity device
since 2007, is approved to treat patients aged 18 and
older who have not been able to lose weight with a
weight loss program, and who have a body mass index of 35 to 45 with at least one other
obesity-related condition, such as type 2 diabetes.
BMI, which measures body fat based on an individual’s weight and height, is used to define the
obesity categories. According to the Centers for Disease Control and Prevention, more than onethird
of all U.S. adults are obese, and people with obesity are at increased risk of heart disease,
stroke, type 2 diabetes and certain kinds of cancer.
“Obesity and its related medical conditions are major public health problems,” said William
Maisel, M.D., M.P.H., deputy director for science and chief scientist in the FDA’s Center for
Devices and Radiological Health. “Medical devices can help physicians and patients to develop
comprehensive obesity treatment plans.”
The Maestro Rechargeable System consists of a rechargeable electrical pulse generator, wire
leads and electrodes implanted surgically into the abdomen. It works by sending intermittent
electrical pulses to the trunks in the abdominal vagus nerve, which is involved in regulating
stomach emptying and signaling to the brain that the stomach feels empty or full. Although it is
known that the electric stimulation blocks nerve activity between the brain and the stomach, the
specific mechanisms for weight loss due to use of the device are unknown.
External controllers allow the patient to charge the device and allow health care professionals to
adjust the device’s settings in order to provide optimal therapy with minimal side effects.
The safety and effectiveness of the Maestro Rechargeable System were evaluated in a clinical
trial that included 233 patients with a BMI of 35 or greater. The weight loss and adverse events
of 157 patients who received the active Maestro device (the experimental group) were compared
to 76 patients in the control group who received a Maestro electrical pulse generator that was not
activated. The study found that after 12 months, the experimental group lost 8.5 percent more of
its excess weight than the control group.

News
Progress Being Made in Infection Control in U.S.
Hospitals; Continued Improvements Needed
January 14, 2015
ATLANTA -- Progress has been made in the effort to
eliminate infections that commonly threaten hospital
patients, including a 46 percent decrease in central
line-associated bloodstream infections (CLABSI)
between 2008 and 2013, according to a report
released today by the Centers for Disease Control and
Prevention. However, additional work is needed to
continue to improve patient safety. CDC’s
Healthcare-Associated Infections (HAI) progress
report is a snapshot of how each state and the country are doing in eliminating six infection types
that hospitals are required to report to CDC. For the first time, this year’s HAI progress report
includes state-specific data about hospital lab-identified methicillin-resistant Staphylococcus
aureus (MRSA) bloodstream infections and Clostridium difficile (C. difficile) infections (deadly
diarrhea).
The annual National and State Healthcare-associated Infection Progress Report expands upon
and provides an update to previous reports detailing progress toward the goal of eliminating
HAIs. The report summarizes data submitted to CDC’s National Healthcare Safety
Network (NHSN), the nation’s healthcare-associated infection tracking system, which is used by
more than 14,500 health care facilities across all 50 states, Washington, D.C., and Puerto Rico.
Healthcare-associated infections are a major, yet often preventable, threat to patient safety. On
any given day, approximately one in 25 U.S. patients has at least one infection contracted during
the course of their hospital care, demonstrating the need for improved infection control in U.S.
healthcare facilities.
“Hospitals have made real progress to reduce some types of healthcare-associated infections - it
can be done,” said CDC Director Tom Frieden, M.D., M.P.H. “The key is for every hospital to
have rigorous infection control programs to protect patients and healthcare workers, and for
health care facilities and others to work together to reduce the many types of infections that
haven’t decreased enough.”
This report focuses on national and state progress in reducing infections occurring within acute
care hospitals. Although not covered by the report released today, the majority of C.
difficile infections and MRSA infections develop in the community or are diagnosed in
healthcare settings other than hospitals. Other recent reports on infections caused by germs such
as MRSA and C. difficile suggest that infections in hospitalized patients only account for about
one-third of all the healthcare-associated infections.

THE ULTIMATE SOURCE
FOR HOT WATER SOLUTIONS
The inventive minds at A. O. Smith are bringing you more options for your
hot water demands than ever before! From standard water heaters to
innovative gas, electric, solar and hybrid technologies, A. O. Smith has the
right water heater to fit the needs of any lifestyle.
VOLTEX ® 50-GALLON
HEAT PUMP WATER HEATER
Highest energy efficiency on the
market at 2.75 EF
11% more efficient than other
ENERGY STAR Heat Pumps
$393 annual savings compared to
standard models
CYCLONE ® Mxi
COMMERCIAL WATER HEATER
Up to 98% thermal efficiency dramatically
lowers operating costs
Modulating models adjust firing rate to
the specific demand, further increasing
efficiency and money savings
Our exclusive advanced electronic control
with built-in diagnostics is network ready
for remote monitoring
TANKLESS
Designed with higher quality
materials for fewer call-backs
Highly efficient (up to .95 EF)
Industry-leading
15-year warranty
More options. Including the right one for your next job.
For more information on all the water heaters A. O. Smith has to offer, visit www.hotwater.com.

News
UTC Donates $1.5 Million to Create New Family
Resource Center at Connecticut Children’s
Medical Center
January 23, 2015
At a press conference Thursday, United
Technologies President and CEO Greg
Hayes announced a $1.5 million grant to
support the United Technologies Family
Resource Center at Connecticut Children’s
Medical Center, which will provide critical
educational resources and support services
to patients and their families. The Hartford,
Connecticut-based hospital welcomed the
significant support and its leadership team expressed confidence that the new Center will bring
hope to families whose youngest members must overcome emotional and physical challenges on
their road to recovery.
“UTC has a long history of supporting leading institutions in our community and is proud to
partner with Connecticut Children’s Medical Center,” Hayes said. “When completed, the Center
will serve as a valuable new resource for children, parents and caregivers in our community, and
we are honored to support Connecticut Children’s investment in improving patient care.”
“For me, the Family Resource Center is a dream come true,” said Hope Feliciano, Connecticut
Children’s Family Advisory Board member, who has three children currently receiving care at
Connecticut Children’s Medical Center. "Now, because of this contribution, families at the
hospital have a place to go to learn, connect with others in the same situation and receive the
resources they need to care for their children and their families.”
In announcing the grant, Hayes was joined by Geraud Darnis, President and CEO, UTC Building
& Industrial Systems, along with Martin Gavin, President and CEO of Connecticut Children’s
Medical Center. Gavin noted that there are currently no designated areas for helping families
understand their children’s unique medical needs.
“The Children’s Medical Center’s mission is to help make the children in Connecticut the
healthiest in the country,” Gavin said. “United Technologies’ commitment to the Family
Resource Center perfectly aligns with that mission, providing services that can impact the lives
of the more than 300,000 patient visitors every year.”

The FiberMark Laser
Economical solution for metal and plastic marking.
Visit epiloglaser.com/dod to see a video of the FiberMark Fusion in action!
T
• Precise metal and plastic marking capabilities
• Generous 24 x 12 or 32 x 20 work area
• Power configurations up to 50 watts
• Compatible with AutoCAD, Bartender,
Illustrator, CorelDRAW, SolidWorks and more
• High-quality, USA-made equipment
Mark a Wide Variety of Materials
• Stainless Steel
• Titanium
• Brass
• Anodized Aluminum
• Steel
• Carbide
• Alloys
• Many Types of Plastic
• And much more
To request a brochure, DVD, and samples, contact us at:
epiloglaser.com/dod • sales@epiloglaser.com • 888-437-4564

Better, Smarter, Healthier: In Historic
Announcement, HHS Sets Clear Goals and
Timeline for Shifting Medicare Reimbursements
from Volume to Value
January 26, 2015
WASHINGTON, DC -- In a meeting with nearly two dozen
leaders representing consumers, insurers, providers, and business
leaders, Health and Human Services Secretary Sylvia M.
Burwell today announced measurable goals and a timeline to
move the Medicare program, and the health care system at large,
toward paying providers based on the quality, rather than the
quantity of care they give patients.
HHS has set a goal of tying 30 percent of traditional, or fee-for-service,
Medicare payments to quality or value through alternative payment models, such as Accountable
Care Organizations (ACOs) or bundled payment arrangements by the end of 2016, and tying 50
percent of payments to these models by the end of 2018. HHS also set a goal of tying 85 percent
of all traditional Medicare payments to quality or value by 2016 and 90 percent by 2018 through
programs such as the Hospital Value Based Purchasing and the Hospital Readmissions
Reduction Programs. This is the first time in the history of the Medicare program that HHS has
set explicit goals for alternative payment models and value-based payments.
To make these goals scalable beyond Medicare, Secretary Burwell also announced the creation
of a Health Care Payment Learning and Action Network. Through the Learning and Action
Network, HHS will work with private payers, employers, consumers, providers, states and state
Medicaid programs, and other partners to expand alternative payment models into their
programs. HHS will intensify its work with states and private payers to support adoption of
alternative payments models through their own aligned work, sometimes even exceeding the
goals set for Medicare. The Network will hold its first meeting in March 2015, and more details
will be announced in the near future.
“Whether you are a patient, a provider, a business, a health plan, or a taxpayer, it is in our
common interest to build a health care system that delivers better care, spends health care dollars
more wisely and results in healthier people. Today’s announcement is about improving the
quality of care we receive when we are sick, while at the same time spending our health care
dollars more wisely,” Secretary Burwell said. “We believe these goals can drive transformative
change, help us manage and track progress, and create accountability for measurable
improvement.”

Increase Your Efficiency.
Improve Their Experience.
MOST COMPREHENSIVE
M E N U AVA I L A B L E
For in vitro diagnostic use only
Improving the patient experience just got easier—
with the i-STAT ® System and Piccolo Xpress ® , now available
from Abbott Point of Care Lab Solutions. Faster turnaround of
lab-quality results to accelerate your clinical decision-making.
More ways to increase patient satisfaction.
© Abbott Point of Care Inc.
400 College Road East, Princeton, NJ 08540
(609) 454-9000 (609) 419-9370 (fax)
www.abbottpointofcare.com
i-STAT is a registered trademark of the Abbott
group of companies in various jurisdictions.
Lab Solutions End User Ad 031433 Rev. A 05/13
Piccolo Xpress ® is a registered trademark of Abaxis, Inc.
Abaxis Part Number 888-3236 Rev. A
To learn more about how our technology, process, and service innovations can help your
facility meet its goals, contact your Abbott Point of Care or Distribution Representative, or
visit www.abbottpointofcare.com and www.piccoloxpress.com.
Technology I Process I Services

News
HHS Proposes Path to Improve Health
Technology and Transform Care
January 30, 2015
WASHINGTON, DC -- The Department of
Health and Human Services’ Office of the
National Coordinator for Health Information
Technology (ONC) today released Connecting
Health and Care for the Nation: A Shared
Nationwide Interoperability Roadmap Version
1.0. The draft Roadmap is a proposal to deliver
better care and result in healthier people through
the safe and secure exchange and use of electronic health information.
“HHS is working to achieve a better health care system with healthier patients, but to do that, we
need to ensure that information is available both to consumers and their doctors,” said HHS
Secretary Sylvia M. Burwell. “Great progress has been made to digitize the care experience, and
now it’s time to free up this data so patients and providers can securely access their health
information when and where they need it. A successful learning system relies on an interoperable
health IT system where information can be collected, shared, and used to improve health,
facilitate research, and inform clinical outcomes. This Roadmap explains what we can do over
the next three years to get there.”
The draft Roadmap builds on the vision paper, Connecting Health and Care for the Nation: A 10-
Year Vision to Achieve an Interoperable Health IT Infrastructure, issued in June 2014. Months
of comment and feedback from hundreds of health and health IT experts from across the nation
through ONC advisory group feedback, listening sessions and an online forum aided in the
development of the Roadmap.
“To realize better care and the vision of a learning health system, we will work together across
the public and private sectors to clearly define standards, motivate their use through clear
incentives, and establish trust in the health IT ecosystem through defining the rules of
engagement. We look forward to working collaboratively and systematically with federal, state
and private sector partners to see that electronic health information is available when and where
it matters,” said Karen DeSalvo, M.D., national coordinator for health IT.
Today’s announcement is linked with the administration’s Precision Medicine Initiative to
improve care and speed the development of new treatments, as well as the Department-wide
effort to achieve better care, smarter spending and healthier people through improvements to our
health care delivery system. As part of this work, HHS is focused on three key areas: (1)
improving the way providers are paid, (2) improving and innovating in care delivery, and (3)

sharing information more broadly to providers, consumers, and others to support better decisions
while maintaining privacy. The draft Roadmap identifies critical actions to achieve success in
sharing information and interoperability and outlines a timeframe for implementation.
The draft Roadmap calls for ONC to identify the best available technical standards for core
interoperability functions. With today’s announcement, ONC is delivering on this action with the
release of the Draft 2015 Interoperability Advisory: The best available standards and
implementation specifications for interoperability of clinical health information (“Standards
Advisory”). The Standards Advisory represents ONC’s assessment of the best available
standards and implementation specifications for clinical health information interoperability as of
December 2014.
“ONC’s interoperability Roadmap will help guide our progress toward seamless integration of
electronic health record data,” said Mr. Christopher Miller, program executive officer for
Defense Healthcare Management Systems within the Department of Defense. “We are proud to
be working closely with ONC and other public and private partners to ensure that our health care
providers have a complete picture of health information from all sources. The availability of this
information increases the medical readiness of our operational forces and enables delivery of the
highest quality care that our service members, veterans and their families deserve. We look
forward to our continued partnership with ONC as we expand the safe and secure exchange of
standardized healthcare data to improve the overall health of our nation.”
“The benefits to patients and to the future of American health care in achieving full
interoperability are enormous. A system built on accessible information and secure, meaningful
data sharing will elevate health care delivery, advance quality and cost-efficiency and enable
new strides in medical research. We applaud HHS and the Office of the National Coordinator
for making interoperability a national priority and we believe that, by bringing together the ideas
and technological expertise from both the public and private sectors, it is a foreseeable and
achievable goal,” said Mary R. Grealy, president, Healthcare Leadership Council.
“Interoperability plays a critical role in improving the quality, cost, and patient experience of
care and is foundational to both consumer decision-making and new models of health care
delivery and payment,” said Janet Marchibroda, director of the Health Innovation Initiative and
executive director of the CEO Council on Health and Innovation at the Bipartisan Policy Center.
“We applaud ONC’s leadership in creating the roadmap and releasing the standards advisory, as
well as its ongoing commitment to public engagement in shaping a path forward.”
“While we have made great strides as a nation to improve EHR adoption, we must pivot towards
true interoperability based on clear, defined and enforceable standards,” said CHIME President
and CEO Russell P. Branzell, F.C.H.I.M.E., C.H.C.I.O. “This Roadmap incorporates a
tremendous amount of stakeholder input and articulates a clear path towards interoperability. It is
a cornerstone in the continuing evolution of federal health IT policymaking.”

News
Cerner Completes Acquisition of Siemens Health
Services
February 2, 2015
KANSAS CITY, MO -- Cerner Corp. today
announced the completion of its acquisition of
Siemens Health Services’ assets, client
relationships and associates.
Cerner and the former Siemens business unit have
a combined annual research and development
investment of more than $650 million. The
cumulative resources are expected to speed
delivery of the company’s next generation of
health IT solutions, enabling clients to control costs and improve health care outcomes in their
communities.
“By combining client bases, investments in R&D and associates, we are in a great position to
lead clients through one of the most dynamic eras in health care,” said Neal Patterson, Cerner
chairman, CEO and co-founder. “Cerner remains focused on key development areas including
population health, physician experience, open platforms, revenue cycle and mobility. We see
these as critical areas of investment to ensure providers can meet growing regulatory demands
and control costs, while continuing to improve quality of care.”
Cerner and Siemens AG, the former parent company of Siemens Health Services, are also
moving forward with a strategic alliance designed to advance industry innovation. The alliance
pairs Cerner’s health IT leadership with Siemens AG’s device and imaging expertise. Each
organization expects to invest up to $50 million during an initial three-year term. The early focus
of the alliance is on integrating diagnostics and therapeutics into the electronic health record.
“Siemens AG is a tenured company with a long and respected track record in health care,” said
Patterson. “A unique feature of this acquisition is we’ll continue working with Siemens AG in a
R&D capacity, in order to advance the interoperability of electronic health records with medical
devices.”
Cerner expects revenue in 2015 to be approximately $4.8 billion to $5 billion, with a client base
spanning more than 30 countries across more than 18,000 facilities.
“The Cerner client family has grown and so has our team. We’re now more than 21,000
associates strong across a global network, all with the singular focus of advancing the state of the
art in health and care,” said Patterson.

Densiier
X3Cycler
OFR
X3C
3 ycle
Xtractor

News
Kallo Selects IBM Cloud Technology to Help
Transform Health Care in Remote Communities
February 5, 2015
ARMONK, NY and MARKHAM, ONTARIO -- IBM and
Kallo Inc. today announced that Kallo has deployed its remote
health-care delivery system on the IBM cloud to bring
advanced real-time medical services to rural areas of the
world.
Kallo’s mobile health-care systems will be used to build and
extend primary care infrastructure in countries including
Guinea and Ghana, making health care accessible to everyone.
The company’s mission is to deliver public health services,
manage communicable and infectious diseases such as Ebola, balance health care delivery
inequities, and address rural disease and health threats. On-demand tele-health services will be
delivered from the company’s global command center in Markham, Ontario and regional
command centers in countries of operation.
IBM provides Kallo with technology consulting and services as well as a cloud infrastructure
hosted at the recently opened SoftLayer cloud center in Toronto. The Toronto location is part of
IBM’s expanding global network of more than 40 centers serving a growing roster of clients
looking to move to hybrid cloud computing environments that encompass open integration, data
control and unique industry expertise.
“The health-care industry is in a time of accelerating change that needs continual innovation,”
said John Cecil, Kallo’s chairman and CEO. “IBM’s cloud technology enables us to ‘reach the
unreached’ to scale and securely deliver North American standards of health care to some of the
world’s most remote or underserved populations.”
Kallo services include MobileCare TM , RuralCare TM , DialysisCare TM , hospital information
systems, tele-health systems, pharmacy information, disaster management, air and surface patient
transportation systems, and clinical training.
The units work in collaboration with each other, with the mobile and rural clinics providing
primary care. Secondary/local specialized care is provided by the regional command centers
while the global command center provides specialized consultative care. With the volume of
cases per country and the privacy and confidentiality standards in cross border tele-health
practice, plans include dedicated global command centers for each country.

Naval Vessels | Commercial Vessels | Coastal Surveillance | Oil Platforms | System Integrators
Our Solutions
• Will connect currently installed equipment and/or new equipment
• Display all sensor data on one screen
• Connect and share data between Ships, land, mobile and off-shore platforms
• Provide a composite track/s from all sensors
Over 800 installations worldwide use SSR.
Do You?

News
St. Jude Medical Launches U.S. Study of the
Country’s Smallest Pediatric Mechanical Heart
Valve
February 10, 2015
ST. PAUL, MN -- St. Jude Medical, Inc., a global
medical device company, today announced the
launch of the HALO U.S. IDE Trial. The trial will
evaluate the safety and efficacy of the St. Jude
Medical Masters HP TM Series 15mm mechanical
heart valve, the smallest pediatric mechanical heart
valve in the world. The HALO Trial will enroll pediatric patients in need of mitral valve
replacement who cannot be implanted with the current range of approved valves without
additional risks and who have no alternative approved treatment options.
In the U.S. alone, more than 35,000 babies are born each year with congenital heart defects,
some of which will impact valve function to the point they’ll require surgical valve replacement.
For many of these patients, mechanical heart valves can effectively mimic natural heart valves,
opening and closing with each heart beat and permitting blood flow into the heart. While there
are several replacement valves of varying size available for older patients, there are no prosthetic
heart valves under 16mm in tissue diameter approved for standard use in newborns, infants and
toddlers.
With limited availability of valves that can suitably match the anatomy of children under the age
of five, some surgeons are forced to implant larger valves in their smallest patients, which may
lead to suboptimal placement that can disrupt hemodynamics, damage to surrounding tissue and
an elevated risk of side effects such as poor blood pressure and potential heart blockage.
“There’s a profound need within the medical community for a mechanical heart valve dedicated
to our tiniest patients who can’t safely be implanted with the current range of valve sizes,” said
Dr. Kirk R. Kanter, professor of surgery at the Emory University School of Medicine and
cardiothoracic surgeon and surgical director of the Heart Transplant Program at Children's
Healthcare of Atlanta. “This small valve represents a big step forward in helping cardiovascular
surgeons provide our patients the optimal level of care.”
In 2007, the U.S. Congress passed the Pediatric Medical Device Safety and Improvement Act to
prompt development of medical devices designed and engineered specifically for the pediatric
patient population. With its legacy of innovation in the field of pediatric cardiology, St. Jude
Medical was uniquely positioned to meet the challenge of designing a mechanical heart valve

that could provide very young patients a chance of survival until they can be implanted with a
larger, permanent valve implant they will carry with them the rest of their life.
The launch of the HALO IDE stems from a new approach to the design, evaluation and
regulatory approval of pediatric heart valves that emerged from an FDA led workshop in 2010
organized in response to the pressing need to develop products for this patient population. In
a speech held in October 2014 the St. Jude Medical pediatric heart valve was cited by FDA
Commissioner Margaret A. Hamburg, M.D., as an example of what collaboration can achieve
when industry, FDA staff, clinicians and academics come together to support pediatric medical
device development.
The HALO Trial will enroll patients at up to 40 sites nationwide. Data collected during the
HALO Trial across all trial sites will be used to support FDA approval of the Masters Series
15mm mechanical heart valve, which is currently available only under “emergency or
compassionate use” protocols.
“The Masters Series 15mm mechanical heart valve was developed based on feedback we
received from physicians and the FDA’s Office of Pediatric Therapeutics, who have expressed
the need for a more suitable mechanical heart valve to offer pediatric patients for which there are
simply no other options,” said Dr. Mark Carlson, vice president of global clinical affairs and
chief medical officer at St. Jude Medical. “As a market leader in pediatric cardiology
solutions, St. Jude Medicalhas the capability to develop devices that fill critical needs, and we
will continue to look for more opportunities to create solutions for some of the biggest
challenges facing pediatric surgeons and cardiologists today.”
St. Jude Medical is a market leader in designing and developing electrophysiology and
interventional cardiology solutions for pediatric patients worldwide. The company currently
offers low voltage and high voltage pacemakers, ablation catheters and occluders to treat
congenital heart defects for the pediatric population. In addition, St. Jude Medical is the most
experienced mechanical valve company in the world, with more than 2 million valves implanted
to date.

that could provide very young patients a chance of survival until they can be implanted with a
larger, permanent valve implant they will carry with them the rest of their life.
The launch of the HALO IDE stems from a new approach to the design, evaluation and
regulatory approval of pediatric heart valves that emerged from an FDA led workshop in 2010
organized in response to the pressing need to develop products for this patient population. In
a speech held in October 2014 the St. Jude Medical pediatric heart valve was cited by FDA
Commissioner Margaret A. Hamburg, M.D., as an example of what collaboration can achieve
when industry, FDA staff, clinicians and academics come together to support pediatric medical
device development.
The HALO Trial will enroll patients at up to 40 sites nationwide. Data collected during the
HALO Trial across all trial sites will be used to support FDA approval of the Masters Series
15mm mechanical heart valve, which is currently available only under “emergency or
compassionate use” protocols.
“The Masters Series 15mm mechanical heart valve was developed based on feedback we
received from physicians and the FDA’s Office of Pediatric Therapeutics, who have expressed
the need for a more suitable mechanical heart valve to offer pediatric patients for which there are
simply no other options,” said Dr. Mark Carlson, vice president of global clinical affairs and
chief medical officer at St. Jude Medical. “As a market leader in pediatric cardiology
solutions, St. Jude Medicalhas the capability to develop devices that fill critical needs, and we
will continue to look for more opportunities to create solutions for some of the biggest
challenges facing pediatric surgeons and cardiologists today.”
St. Jude Medical is a market leader in designing and developing electrophysiology and
interventional cardiology solutions for pediatric patients worldwide. The company currently
offers low voltage and high voltage pacemakers, ablation catheters and occluders to treat
congenital heart defects for the pediatric population. In addition, St. Jude Medical is the most
experienced mechanical valve company in the world, with more than 2 million valves implanted
to date.

News
New Affordable Care Act Initiative to Encourage
Better Oncology Care
February 12, 2015
BALTIMORE, MD -- The U.S. Department of
Health and Human Services (HHS) today
announced a new multi-payer payment and care
delivery model to support better care coordination
for cancer care as part of the Department’s ongoing
efforts to improve the quality of care patients
receive and spend health care dollars more wisely,
contributing to healthier communities. The initiative
will include 24-hour access to practitioners for beneficiaries undergoing treatment and an
emphasis on coordinated, person-centered care, aimed at rewarding value of care, rather than
volume.
Cancer is one of the most common and devastating diseases in the United States: more than 1.6
million people are diagnosed with cancer each year in this country. According to the National
Institutes of Health, cancer cost the United States an estimated $263.8 billion in medical costs
and lost productivity in 2010. A majority of those diagnosed are over 65 years old and Medicare
beneficiaries.
“Based on feedback from the medical, consumer and business communities, we are launching
this new model of care to support clinicians’ work with their patients,” said Patrick Conway,
M.D., CMS chief medical officer and deputy administrator for innovation and quality. “We aim
to provide Medicare beneficiaries struggling with cancer with high-quality care around the clock
and to reward doctors for the value, not volume, of care they provide. Improving the way we pay
providers and deliver care to patients will result in healthier people.”
As part of the Department’s “better care, smarter spending, healthier people” approach to
improving health delivery, the Oncology Care Model is one of many innovative payment and
care delivery models developed by the Centers for Medicare & Medicaid Services
(CMS) Innovation Center and advanced by the Affordable Care Act. The model was created in
response to feedback from the oncology community, patient advocates, and the private sector
that a new way of paying for and delivering oncology care is needed. This model will invest in
physician-led practices, allowing the practices to innovate and deliver higher-quality care to their
patients. CMS is seeking the participation of other payers in the model to leverage the
opportunity to transform care for oncology patients across a broader population.

WHEN THE MISSION CALLS FOR DG SHIPPING,
MAKE SURE NOTHING STANDS IN YOUR WAY.
When you need to ship dangerous goods, Labelmaster is there to answer the call. With fully-customizable products, software
and services, we’re here to ensure the DG supplies you ship—from weapons and ammunition to explosives and more—get where
you need them. Our experts stay up-to-date on regulations and offer the tools and solutions you need to keep even your
toughest shipments moving. Whatever the mission.
DUNS # 117395095 Cage Code # 67634
Labelmaster.com/gsa-contract • governmentsales@labelmaster.com • 773.279.2343

News
Cerner, Mortara Introduce CareAware
Waveform Management
February 12, 2015
KANSAS CITY, MO -- Cerner Corp., one of the
largest health information technology suppliers, and
development partner Mortara Instrument, a leading
U.S. manufacturer of diagnostic cardiology
instrumentation, including multi-parameter patient
monitoring, have joined together to introduce
CareAware Waveform Management. The new
solution displays waveforms and other physiological
data from patient monitoring systems and integrates them into the Electronic Health Record
(EHR).
“This solution is one of the final steps toward creating a fully digital hospital,” said Stephanie
Rogers, RN-BC and director of critical care at Cerner. “Although hospitals are working toward a
fully integrated digital care process, today they are still subjected to printing rolls of paper strips
to monitor patient waveforms. We expect the integration of physiological waveforms and data
into the electronic health record will lead to enhanced decision-making and improved patient
outcomes by streamlining documentation and viewing of waveforms in the context of other
relevant patient information.”
With CareAware Waveform Management, clinicians will be able to view physiologic
waveforms, data and alarms on devices with access to the patient record. Caregivers will be able
to monitor patient waveforms in the context of other relevant patient information. The solution
will help streamline documentation by enabling clinicians to electronically view, measure,
annotate and save waveform strips to the EHR, eliminating one of the final pieces of paper in the
hospital setting.
“Bringing Mortara’s waveform management capabilities to the Cerner solution reflects our
vision of fully integrating medical devices into ever more connected EHR systems,” said Dr.
Justin Mortara, CEO of Mortara. “We are confident that, by extending waveform capabilities to
CareAware, clinicians will realize easier access to relevant data.”
The University of Missouri (MU) Health Care and Cerner leveraged their collaborative
relationship with the Tiger Institute to alpha test the new waveform technology with live data.
“MU Health Care is committed to providing high-quality patient care throughout our clinical
enterprises,” said Bridgett Robbins, RN, clinical manager, MU Health Care. “As the alpha client
of Cerner’s CareAware Waveform Management solution, this partnership helps us move toward
our goal of implementing innovative and progressive processes to provide superior care.”

Panther provides Premium Logistics ® solutions
for the domestic and international movement of
arms, ammunition and explosives.
With premium logistics services on six continents,
Panther offers bulletproof SOPs, world-class tracking
and tracing, and security-cleared personnel.
ITAR
COMPLIANT
Transportation Protective Services:
Constant Surveillance Service (CIS)
Dual Driver Protective Service (DDP)
Protective Security Service (PSS)
Security Escort Vehicle Service (SEV)
Motor Surveillance Service (MVS)
Satellite Motor Surveillance (SNS)
Call us today to find out how to best
ship your high-risk, time sensitive freight.
Call (866) 455-8205.
www.pantherexpedite.com

NIH-Funded Scientists Create Potential Long-
Acting HIV Therapeutic
News
February 19, 2015
Scientists have created a new molecule that shows promise
for controlling HIV without daily antiretroviral drugs. The
molecule foils a wider range of HIV strains in the
laboratory than any known broadly neutralizing HIV
antibody and is more powerful than some of the most
potent of these antibodies. In addition, the molecule safely
protected monkeys from infection with an HIV-like virus
during a 40-week study period. Together, the data suggest that the molecule could, with further
research, be used to subdue HIV in humans. The authors note that the molecule potentially could
be used as both a preventative drug and as a treatment. The new findings appear in the February
18 issue of the journal Nature.
“This innovative research holds promise for moving us toward two important goals: achieving
long-term protection from HIV infection, and putting HIV into sustained remission in
chronically infected people,” said Anthony S. Fauci, M.D., director of the National Institute of
Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
The research was led by Michael Farzan, Ph.D., a professor in the department of infectious
diseases at The Scripps Research Institute in Jupiter, Florida. The work was funded primarily by
NIAID.
The new molecule is called eCD4-Ig and works by tightly binding to two unchanging sites on the
surface of HIV that the virus uses to attach to receptors on cells called CD4 and CCR5.
Typically, when HIV attaches to these receptors, it unlocks a door to the cell and gets inside.
However, when eCD4-Ig binds to HIV, it effectively takes away the virus’s key, locking it out of
the cell and preventing it from multiplying. To make eCD4-Ig, the scientists took an antibodylike
molecule that latches onto the CD4 binding site but does not neutralize HIV on its own, and
fused it with a short protein fragment that attaches tightly to the CCR5 binding site. Together,
these two arms of the molecule are much more effective at stopping HIV than either one is alone.
To test whether eCD4-Ig would protect monkeys from an HIV-like virus (simian
immunodeficiency virus, or SIV), the scientists synthesized genetic instructions for making the
molecule and placed them inside a harmless carrier virus called adeno-associated virus, or AAV.
This gene-therapy tool was designed such that once the AAV-modified virus infected a cell, it
would cause the cell to make eCD4-Ig indefinitely. The researchers injected the genetically
modified AAV into four monkeys. Then they exposed both the treated monkeys and four
untreated monkeys to SIV six times at increasingly higher doses over a 34-week period. None of
the treated monkeys became infected with SIV, while all of the untreated monkeys did.

TÜV SÜD America
Chemical, Oil and Gas
TÜV SÜD America, Chemical, Oil and Gas helps people
and organizations drive business performance to levels of
excellence. We provide effective training paths to support the
growth of individuals and organizations, whether in one of our
public training programs or in customized in-house solutions.
To learn more, visit www.tuv-sud-america.com/COG-Training
TÜV SÜD America 1475 East Sam Houston Parkway South, Suite 100, Pasadena, Texas 77503 United States
(800) 747-4099 info@tuvam.com www.tuv-sud-america.com/c.o.g

News
Booz Allen Hamilton Partners with HITRUST on
Series of Cyber Preparedness and Education
Town Halls for Healthcare Industry
February 19, 2015
MCLEAN, VA -- Booz Allen Hamilton has
partnered with the Health Information Trust
(HITRUST) Alliance to hold a CyberRX 2.0
cyber preparedness, education and simulation
event in Washington, D.C., on March 25, 2015.
The Cyber Town Hall event will feature
participants from the healthcare industry as
well as from the U.S. Department of Health and
Human Services (HHS), Federal Bureau of Investigation (FBI) and the U.S. Department of
Homeland Security (DHS).
This “Cyber Town Hall” session, which is part of the ongoing HITRUST CyberRX 2.0 program,
is the first in a series of events Booz Allen will host in major cities across the U.S. The Cyber
Town Hall session in D.C. will provide an opportunity for attendees from the government,
insurers, hospitals and other providers to learn how to assess their ability to respond effectively
to cyber threats and attacks, and understand what resources from HHS, FBI, DHS and HITRUST
are available to improve collaboration and cyber intelligence sharing.
“Given recent high-profile cyber attacks perpetrated against the health care industry and the
overall increase in incidents HITRUST is seeing in its cyber center both in volume and
sophistication, the CyberRX Cyber Town Hall events are more urgent and critical than ever. We
are pleased to partner with Booz Allen Hamilton and its recognized experts in cybersecurity
programs, to offer the D.C. and other events around the country,” said Daniel Nutkis, CEO,
HITRUST. “HITRUST is committed to continuing to provide critical support and protect the
U.S. healthcare industry from disruption by cyber attacks through important programs including
HITRUST CyberRX, the HITRUST Cyber Threat Intelligence and Incident Coordination Center
(C3), HITRUST Cyber Threat Briefings and the HITRUST Cyber Threat XChange. Thousands
of healthcare organizations have already benefitted from these services and we expect to see a
critical mass of interest and participation this year that will transform the way the industry
approaches information security.”
The Cyber Town Hall session allows organizations to learn about the CyberRX 2.0 program and
assess their response and threat preparedness against healthcare cybersecurity attacks.

Your one stop shop for Materials Testing
Struers is the world leader in materials testing. Since 1875
we’ve provided our customers with the absolute finest equipment,
consumables, and application knowledge for quality control,
research, and failure analysis. Contact us today, and experience:
• Industry-leading, high quality products
• Best-in-class customer service
• Unparalleled application and technical support
• Streamlined purchasing
USA & CANADA
Struers Inc.
Tel: 440-871-0071
info@struers.com
www.struers.com

News
Surescripts Leverages Technology to Help
Doctors Address Prescription Fraud and Abuse
February 19, 2015
ARLINGTON, VA -- Surescripts, the nation’s
largest health information network, is working
industry-wide to improve care and curb prescription
fraud, diversion and abuse by connecting pharmacists
and doctors and encouraging the adoption
of electronic prescribing of controlled
substances (EPCS). In 2015, Surescripts expects to
deliver at least 5 million electronic prescriptions of
controlled substances, representing an increase of nearly 400 percent over the prior year.
“A number of complex regulatory and technology requirements exist, and the amount of
misinformation about EPCS is daunting, with many prescribers unaware that they have this
option or that it’s legal,” said David Yakimischak, Executive Vice President and General
Manager at Surescripts. “By eliminating the paper prescription and connecting physicians and
pharmacists electronically, there is an opportunity to improve care, reduce fraud, and identify
potential instances of abuse.”
Currently, electronic prescribing of controlled substances is legal in 48 states plus the District of
Columbia, and lawmaking is pending in Montana and Missouri to allow the practice by the
middle of this year. New York is taking it a step further and requiring that prescriptions for all
drugs, including controlled substances, be delivered electronically.
“It’s important that we take steps as an industry to enable the flow of information about
prescribing patterns for controlled substances to help manage fraud and abuse,” said Bob Robke,
Vice President for Interoperability Strategies and Solutions at Cerner. “Creating an interoperable
network for providers and pharmacies to share this information gets us one step closer to
breaking down interoperability barriers across all of health care.”
Across the country, more than 70 percent of pharmacies are ready to receive electronic
prescriptions for controlled substances, but the number of prescribers who are ready to send them
is approximately six percent. This is despite the fact that more than 60 percent of prescribers who
already e-prescribe use software that has at least one EPCS-certified version enabled today.
Beyond the required software updates, medical practices must complete several additional steps
before they can legally send electronic prescriptions for controlled substances.
To make this process easier for doctors and to help them get started, Surescripts has created a
step-by-step video guide and tools available at www.getEPCS.com.

HIGH TEMPERATURE MATERIALS FOR
ELECTRICAL l STRUCTURAL l INDUSTRIAL l MEDICAL
APPLICATIONS TO 4000ºF
Flexible Conductive Silver Based Epoxy
Duralco 125 thermally conductive electrical epoxy bonds to most metals, ceramics
and plastics to form a stress-free adhesive bond. Continuous service up to 450ºF.
High Temperature Low Expansion Adhesive
Resbond 905 Quartz is formulated for bondng low
expansion and thermal shock resistant ceramics. Ideal for
electronic and metallurgical applications to 2500ºF.
Thermally Conductive Adhesives
Duralco 132 thermally conductive adhesives combine
Cotronics’ unique, high temperature resins with highly
conductive fillers to form thermally conductive, adhesive
bonds with continuous service up to 500ºF.
High Expansion Adhesive
Thermeez 7030 bonds and protects to 1800ºF. Apply to
ceramics, ceramic cloths, door and tadpole gaskets and
metals. Excellent adhesion to steel, stainless, aluminum,
lead and ceramics.
High Purity, Alumina Adhesive Protects
Critical Electronic Components
Resbond 989 offers continuous protection to 3000ºF. Apply directly to metals, glass,
ceramics, graphite and silicon carbide. Provides high bond strength and excellent
electrical, moisture, chemical and solvent resistance for bonding and sealing.
You have challenging applications… we have solutions!
High Temperature Products Since 1971
131 47th Street, Brooklyn, New York 11232-4225
Call: 718.788.5533 Fax: 718.788.5538 Email: sales@cotronics.com Web: www.cotronics.com
TECH SUPPORT I CUSTOM FORMULATIONS I QUANTITY PRICING

News
HHS Invests in Enhancing Domestic
Preparedness Efforts for Ebola
February 20, 2015
WASHINGTON, DC -- The Department of Health and
Human Services released a new funding opportunity
announcement (FOA) today: the Hospital Preparedness
Program (HPP) Ebola Preparedness and Response
Activities. This funding opportunity will award a total of
$194,500,000 to states and other grantees for Ebola
health care system preparedness and response and the
development of a regional Ebola treatment strategy.
This funding, in addition to the Ebola emergency funds that will soon be awarded through
the Public Health Emergency Preparedness (PHEP) program, provides a total investment of
$339,500,000 to enhance state, local and health care system preparedness for Ebola through the
emergency appropriations passed with bipartisan support in Congress in December 2014. These
funds build on gains that have been made in health care and public health preparedness efforts
over the past decade through the HPP and PHEP cooperative agreements with states.
“I’d like to thank cities, states, and hospitals across the country and the public health community
for stepping up and taking action,” said HHS Assistant Secretary for Preparedness and Response
(ASPR) Dr. Nicole Lurie. “We are building on the work we’ve already done and further
investing in domestic preparedness to protect the public’s health from Ebola, as well as boosting
preparedness for many other types of health threats.”
Since last fall, the United States has strengthened domestic preparedness and response efforts.
State and local public health officials, with technical assistance from the Centers for Disease
Control and Prevention (CDC) and ASPR, collaborated with hospital officials across the U.S. to
increase domestic capacity to care for patients with Ebola.
Important lessons were also learned during the response effort. Safety of health care workers
must be foremost in health care system preparedness and response activities; the care of Ebola
patients is clinically complex and demanding; and early case recognition is critical for preventing
spread and improving outcomes. Assuring that Ebola patients are safely and well cared for in the
U.S. health care system and that frontline providers are trained to recognize and isolate a person
with suspected Ebola are the cornerstones of the Hospital Preparedness Program Ebola funding
announcement.

Keeping pace with the needs
of the composites industry.
ADVANCED FILAMENT WINDING SYSTEMS
Q UALITY
I NNOVATION
L ONGEVITY
Our line of filament winders begins with a “use it right out of the box” 2 axes
model, to a workhorse production unit that can be configured with 3-6 axes of
computer controlled motion. All winders can be customized. We also offer precision
tensioning creel systems, fiber delivery systems, extraction systems and mandrels.
FILAMENT WINDING MACHINES ~ MACHINE CONTROLS
AUXILIARY EQUIPMENT ~ PATTERN SOFTWARE
FIBER DELIVERY SYSTEMS ~ TENSIONERS
RETROFITTING AND MORE

News
3D Systems Debuts Powerful New All-In-One
Medical 3D Printer at LMT LAB DAY Chicago
February 24, 2015
ROCK HILLS, SC -- 3D Systems announced today the
immediate availability of its revolutionary all-in-one medical 3D
printer, the ProJet 3510 DPPro, which the company plans to
debut at LMT LAB DAY Chicago 2015. The ProJet 3510
DPPro, the latest in 3DS' stellar MultiJet (MJP) line, gives
medical and dental labs the power to print precision dental waxups;
durable implant drill guides; temperature-resistant, thermoformable
orthodontic patterns; and crown and bridge molds
interchangeably, at up to twice the throughput of today's printers.
Armed with the ProJet 3510 DPPro's game-changing speed, throughput and versatility, dental
and medical labs can print precision, personalized medical tools and devices created directly
from patients' data, in a matter of hours—all in a smaller footprint than existing medical printers.
“Our primary purpose is to democratize access to more affordable and powerful tools for the
benefit of our customers. With its high resolution, high capacity and expanded material
compatibility, the DPPro can support the widest range of medical applications, at a very low cost
of ownership,” said Buddy Byrum, Vice President, Product Management, 3DS. “LMT LAB
DAY is the perfect venue to demonstrate this new, multipurpose machine to those who will
benefit most from it.”
Engineered specifically for demanding dental and medical lab environments, the multipurpose
ProJet 3510 DPPro 3D printer provides round-the-clock printing capabilities and features a large
build volume, allowing lab managers to rethink maximum throughput and tighten production
schedules. With the ProJet 3510 DPPro's variety of specifically engineered materials, labs can
print enhanced, highly accurate wax-ups for crowns, bridges and partial denture frameworks, in
addition to working models for crown and bridge, orthodontic, partial dentures, and medical
models, such as a jaw models, in USP Class VI-capable VisiJet ® Stoneplast.
The ProJet DPPro also produces superior, customized implant drill guides in a durable
biocompatible plastic material. Enhanced with efficient material use, low-maintenance operation
and an unprecedented five-year print head warranty, the ProJet DPPro conveniently melds with
existing workflows and pays owners back on their investment faster.

New Data from CCN Demonstrate Potential of
CT to Transform the Cardiac Care Pathway
News
March 4, 2015
VIENNA -- Centre Cardiologique du Nord, Saint
Denis today presented data at the European
Congress of Radiology (ECR) that show GE
Healthcare’s new Revolution* CT scanner could
impact the way in which coronary artery disease is
diagnosed and managed. The findings of the study,
which was carried out under the leadership of Drs.
Jean-Louis Sablayrolles, Laurent Macron and Jacques Feignoux, showed GE Healthcare’s
Revolution CT produced high quality images using lower doses of radiation for cardiac exams
even with clinically-challenging patients, contributing to more confident diagnoses at lower
patient doses. According to the authors, the findings suggest the possibility that high
performance CTs such as Revolution CT could be used as a first-line examination in the
evaluation of coronary artery disease.
Coronary Computed Tomography Angiography (CCTA) is a well-established non-invasive
imaging technique used in the detection of coronary artery disease (CAD). It offers an alternative
to exercise stress tests or coronary angiography (IC) for diagnosis, the latter being an invasive
procedure that uses a catheter threaded through the blood vessels to the heart. However, a
number of factors limit the use of CCTA in cardiac care. Patients with high heart rates or
arrhythmia can be challenging to diagnose with confidence because high heart rates can
introduce motion artefacts, making it difficult to find an appropriate phase of the cardiac cycle
suitable for the analysis of all coronary segments. Levels of radiation exposure for patients are
also a concern. GE Healthcare’s Revolution CT has been developed to help address these
challenges, allowing the heart to be imaged in one beat, whatever the heart rate, while helping to
reduce dose by up to 82% when the new reconstruction algorithm ASiR-V* is applied1.
The study at CCN scanned 58 patients with high heart rates (>65 bpm) to compare the image
quality and radiation dose of the Revolution CT 512-slice scanner with the previous generation
128-slice technology (Discovery CT750 HD). 58 patients with high heart rates were scanned in
two groups of 29. The study found that Revolution CT images ranked higher on a five-point
Likert scale. The Revolution CT also successfully imaged a very high percentage of assessable
coronary segments, even though this group of challenging patients had a mean heart rate 75.7 ±
9.9 bpm.
Dr. Sablayrolles, head of CT Cardiac Imaging Radiology at Centre Cardiologique de Nord
(CCN) in Saint-Denis, France was the first user of Revolution CT in Europe.

Northeastern University Researchers Find
Inhaling Supplemental Oxygen Can Awaken
Anti-Tumor Cells
News
March 4, 2015
BOSTON, MA -- Northeastern University
researchers have found that inhaling supplemental
oxygen—40 to 60 percent oxygen as opposed to
the 21 percent oxygen in air—can weaken
immunosuppression and awaken anti-tumor cells.
The new approach, some 30 years in the making,
could dramatically increase the survival rate of
patients with cancer, which kills some 8 million
people each year. The breakthrough findings were published Wednesday in Science Translational
Medicine.
Michail Sitkovsky, an immunophysiology researcher at Northeastern,and his team found that
supplemental oxygenation inhibits the hypoxia-driven accumulation of adenosine in the tumor
microenvironment and weakens immunosuppression. This, in turn, could improve cancer
immunotherapy and shrink tumors by unleashing anti-tumor T lymphocytes and natural
killer cells.
Breathing supplemental oxygen opens up the gates of the tumor fortress and wakes up ‘sleepy’
anti-tumor cells, enabling these soldiers to enter the fortress and destroy it,” explained Sitkovsky,
the Eleanor W. Black Chair and Professor of Immunophysiology and Pharmaceutical Biotechnology
at Northeastern and the founding director of the university’s New England Inflammation
and Tissue Protection Institute. “However, if anti-tumor immune cells are not present, oxygen
will have no impact.”
The findings build upon Sitkovsky’s previous research and represent the culmination of his life’s
work, which has been supported by Northeastern and the National Institutes of Health. In the
early 2000s, Sitkovsky made an important discovery in immunology, which has come to inform
his research in cancer biology. He found that a receptor on the surface of immune cells—the
A2A adenosine receptor—is responsible for preventing T cells from invading tumors and for
“putting to sleep” those killer cells that do manage to enter into the tumors.
His latest work shows that supplemental oxygen weakened tumor-protecting signaling through
the A2A adenosine receptor and wakes up the T cells that were able to invade lung tumors. “This
discovery shifts the paradigm of decades-long drug development, a process with a low success
rate,” Sitkovsy said.

News
Saving Precious Time: Siemens’ New Ultrasound
System for Faster Imaging
March 4, 2015
ERLANGEN, GERMANY -- At this year's European
Congress of Radiology (ECR) in Vienna, Austria,
Siemens Healthcare introduces its new hand-carried
Acuson P500 ultrasound system, Frosk edition. It allows
reliable and fast imaging by offering new and timetested
high-end imaging technology in a compact and
easy-to-use device, making it particular suitable for the
use in the emergency medicine and general imaging.
When every second counts, clear image quality means precious time saved. Hence Siemens'
newest member in the Acuson P Family of portable ultrasound systems, the Acuson P500, Frosk
edition introduces two new premium technologies that continuously provide sharp ultrasound
images, regardless of patient and probe motion: Dynamic Persistence and patent-pending Auto
Flash Artifact Suppression. Both technologies were specially designed for the new system and
work together to detect movements that affect image quality, and automatically reduce noise
while simultaneously enhancing color sensitivity for clear images. Additionally, the new
ultrasound system features established high-performance imaging tools migrated from Siemens'
Acuson S Family of premium ultrasound systems such as Advanced SieClear spatial
compounding and Dynamic TCE tissue contrast enhancement technology for excellent 2D color
Doppler image quality.
All this comes in a compact notebook format of 15-inches (38 cm), weighing under 8 kilograms.
Equipped with a battery that offers up to 60 minutes of scanning time, the new platform can be
easily carried and positioned in any clinical environment, helping clinicians make quick
decisions even in difficult scanning conditions. With a standard rapid boot-up feature, the system
is ready for scanning in less than 30 seconds.
The Acuson P500 system's clear user interface is easy to learn and operate for users of all
experience levels. It features a highly sensitive touch screen display with advanced infrared (IR)
technology for accurate gesturing. A dual interface control panel offers flexible use of the touch
screen or a traditional control panel based on each user's own scanning preferences, allowing
them to spend less time on the system and more time on the patient. “The compact Acuson P500
system, Frosk edition is ideal for any setting where performance is critical and space is limited -
for instance in emergency settings,” says Jeffrey Bundy, CEO of the Siemens Healthcare
Ultrasound Business Unit. “The combination of our two new motion controlling technologies
designed specifically for this platform offer unprecedented image quality and ease of use,
meeting the needs of general imaging and point-of-care ultrasound.”

The fastest weigh
to zero waste.
If your organization has a goal to achieve
zero waste, then you need to know how
you’re measuring up along the way.
LoadMan can help by accurately
weighing each and every load with 99%
accuracy. But the measurement doesn’t
stop there–you need data. LoadMan’s
weigh-in-motion, on-board truck scale
system gives you an end-to-end solution.
LoadMan’s fully automated system will
let your drivers drive while collecting and
sharing data in real time. And using LoadMan
Load Management software, custom reports
are just a few key strokes away.
Start tracking your progress to zero
waste today.
It’s all about the data.
www.LoadMan.com
888.LoadMan (888.562.3626)
contact@LoadMan.com

News
GE Ventures and Stanford Health Care Launch
Digital Health Company
March 5, 2015
MENLO PARK, CA -- Today, GE Ventures and
Stanford Health Care announced the launch
of Evidation Health, an independent company
committed to improving health outcomes with
evidence-based digital medicine. Focused on generating
real-world clinical and economic evidence for digital
health products and platforms, Evidation Health
combines health outcomes data with new approaches to
predictive analytics to identify and deploy the most effective and efficient patient management
strategies and interventions.
Evidation Health Chief Executive Officer Deborah Kilpatrick, said, “Our company has the core
capabilities to make precision digital medicine a reality. We envision a digital health-enabled
future where clinical interventions can be customized and concentrated in ways that maximize
clinical and economic benefit for payers, providers and, most importantly, patients.”
According to digital health seed fund Rock Health, more than $4B was invested in over 250
digital health companies in 2014 alone. As this new breed of disruptive tools and technologies
enter the market, healthcare purchasers struggle to identify those that will most significantly
impact outcomes and improve patient care.
Rowan Chapman, managing director of new business creation at GE Ventures said, “Digital
disruption in the health care industry has introduced a number of new but often unproven
products and services. With Evidation Health, we will be able to not only improve outcomes, but
also ensure that the best products reach patients.”
To accelerate commercial progress, Evidation Health joined forces with The Activity Exchange,
a digital health company with strong predictive analytics capabilities, and closed its Series A
financing in January of 2015. The round was led by GE Ventures, with participation from Asset
Management Ventures and Rock Health. The company is focused on forging new partnerships
while continuing its corporate and academic collaborations with Humana, Biogen Idec., Sanofi,
Harvard Business School and Wharton, amongst others.
Stanford Health Care President and CEO Amir Dan Rubin, said “Stanford Health Care is
committed to delivering integrated solutions to the complex problems patients face, and those
solutions will increasingly be advanced through digital health.”

Partner with
the company
that works
as hard
as you do.
1 – Superior Training
Free 1-day training at
Bird•B•Gone’s manufacturing
facility in Santa Ana, CA.
2 – Superior Products
Full line of products available:
bird spikes, bird netting,
electric track and more!
3 – Superior Service
Our bird control engineers lead
the industry with more than 90
years of hands on experience.
Professional Bird Control Products
Call today for detailed advice from the leading industry experts in bird control
877.998.1945
www.birdbgone.com

FDA Approves First Biosimilar Product Zarxio
News
March 6, 2015
The U.S. Food and Drug Administration today
approved Zarxio (filgrastim-sndz), the first
biosimilar product approved in the United States.
Biological products are generally derived from a
living organism. They can come from many
sources, including humans, animals,
microorganisms or yeast.
A biosimilar product is a biological product that is approved based on a showing that it is highly
similar to an already-approved biological product, known as a reference product. The biosimilar
also must show it has no clinically meaningful differences in terms of safety and effectiveness
from the reference product. Only minor differences in clinically inactive components are
allowable in biosimilar products.
Sandoz, Inc.’s Zarxio is biosimilar to Amgen Inc.’s Neupogen (filgrastim), which was originally
licensed in 1991. Zarxio is approved for the same indications as Neupogen, and can be
prescribed by a health care professional for:
patients with cancer receiving myelosuppressive chemotherapy;
patients with acute myeloid leukemia receiving induction or consolidation chemotherapy;
patients with cancer undergoing bone marrow transplantation;
patients undergoing autologous peripheral blood progenitor cell collection and therapy;
and
patients with severe chronic neutropenia.
“Biosimilars will provide access to important therapies for patients who need them,” said FDA
Commissioner Margaret A. Hamburg, M.D. “Patients and the health care community can be
confident that biosimilar products approved by the FDA meet the agency’s rigorous safety,
efficacy and quality standards.”
The Biologics Price Competition and Innovation Act of 2009 (BPCI Act) was passed as part of
the Affordable Care Act that President Obama signed into law in March 2010. The BPCI Act
created an abbreviated licensure pathway for biological products shown to be “biosimilar” to or
“interchangeable” with an FDA-licensed biological product, called the “reference product.” This
abbreviated licensure pathway under section 351(k) of the Public Health Service Act permits
reliance on certain existing scientific knowledge about the safety and effectiveness of the
reference product, and enables a biosimilar biological product to be licensed based on less than a
full complement of product-specific preclinical and clinical data.

EVERY SECOND COUNTS
Product capabilities include:
• Identify gases and vapors at the parts per million to parts
per billion levels
• Innovative library searching software that provides answers
instantly while in the field
• Ruggedized for use in the hot zone and extreme
environments
• Superior performance enables the detection of emerging
threats
GUARDION
Smallest, Lightest, and Fastest Portable GC/MS
Chemical Identifier
For further information on the product, service or sales, please access
smithsdetection.com or contact usa@smithsdetection.com
GUARDION is a trademark of Smiths Detection Group Ltd.

Concordia Healthcare Corp. to Acquire Covis
Pharma Commercial Assets for $1.2 Billion
News
March 9, 2015
TORONTO -- Concordia Healthcare Corp.
(“Concordia” or the “Company”), a diverse
healthcare company focused on legacy
pharmaceutical products, orphan drugs, and medical devices for the diabetic population, today
announced it has entered into a definitive asset purchase agreement to acquire substantially all of
the commercial assets of privately held Covis Pharma S.à.r.l and Covis Injectables, S.à.r.l
(together “Covis”) for US$1.2 billion in cash. All financial references are in U.S. dollars unless
otherwise noted.
The Covis drug portfolio being acquired (the “Portfolio”) consists of 18 branded and authorized
generic products with stable revenue, strong margins and free cash flow. The distinctive product
portfolio includes branded pharmaceuticals, injectables and authorized generics that address life
threatening and other serious medical conditions in various therapeutic areas including
cardiovascular, central nervous system, oncology and acute care markets. Key products are
Nilandron®, for the treatment of metastatic prostate cancer; Dibenzyline®, for the treatment of
pheochromocytoma; Lanoxin®, for the treatment of mild-to-moderate heart failure and atrial
fibrillation; and, Plaquenil®, for the treatment of lupus and rheumatoid arthritis.
In its fourth quarter of 2014, Covis expects to have revenue between US$47 and US$52
million related to the Portfolio. Overall for 2014, Covis expects to have revenue
between US$140 and US$145 million with a gross profit margin of approximately 90%.
Concordia believes that it can integrate the Portfolio it is acquiring into its existing business and
leverage its existing infrastructure. Through the elimination of redundant distribution and G&A
expenses, Concordia expects to recognize immediate synergies of approximately $20 million.
“Covis’ strong commercial momentum will have an immediate and material impact on our top
and bottom line financial results,” said Mark Thompson, Chief Executive Officer of Concordia.
“In the longer-term, this transaction creates greater scale and diversification for Concordia,
which should support the continued execution of our aggressive growth plans.”

MITI Portable DeCon “U” Shower
Ancillary Equipment
DeCon “U” Shower
MADE IN USA
High Pressure
Manifolds
WYE Fittings
FR In-Line
Pressure
Reducers
FSI Soap
Injectors
3183 HALL AVENUE
GRAND JUNCTION
COLORADO 81504
TOLL FREE
866-545-6484
PHONE (970) 243-9500
FAX (970) 243-9200
sales@mitico.com
www.mitico.com
All products GSA Approved GS 07F 5622R

News
Apple Introduces ResearchKit, Giving Medical
Researchers the Tools to Revolutionize Medical
Studies
March 9, 2015
SAN FRANCISCO -- Apple® today announced
ResearchKit, an open source software framework
designed for medical and health research, helping doctors
and scientists gather data more frequently and more
accurately from participants using iPhone® apps. Worldclass
research institutions have already developed apps
with ResearchKit for studies on asthma, breast cancer,
cardiovascular disease, diabetes and Parkinson’s disease. Users decide if they want to participate
in a study and how their data is shared.
“iOS apps already help millions of customers track and improve their health. With hundreds of
millions of iPhones in use around the world, we saw an opportunity for Apple to have an even
greater impact by empowering people to participate in and contribute to medical research,” said
Jeff Williams, Apple’s senior vice president of Operations. “ResearchKit gives the scientific
community access to a diverse, global population and more ways to collect data than ever
before.”
ResearchKit turns iPhone into a powerful tool for medical research. When granted permission by
the user, apps can access data from the Health app such as weight, blood pressure, glucose levels
and asthma inhaler use, which are measured by third-party devices and apps. HealthKit is a
software framework Apple introduced with iOS 8 to provide developers the ability for health and
fitness apps to communicate with each other. ResearchKit can also request from a user, access to
the accelerometer, microphone, gyroscope and GPS sensors in iPhone to gain insight into a
patient’s gait, motor impairment, fitness, speech and memory.
ResearchKit also makes it easier to recruit participants for large-scale studies, accessing a broad
cross-section of the population—not just those within driving distance of an institution. Study
participants can complete tasks or submit surveys right from the app, so researchers spend less
time on paperwork and more time analyzing data. ResearchKit also enables researchers to
present an interactive informed consent process. Users choose which studies to participate in and
the data they want to provide in each study.
“We’re excited to use these new ResearchKit tools from Apple to expand participant recruitment
and quickly gather even more data through the simple use of an iPhone app. The data it will
provide takes us one step closer to developing more personalized care,” said Patricia Ganz, MD,

professor at the UCLA Fielding School of Public Health and Director of Cancer Prevention &
Control Research at UCLA’s Jonsson Comprehensive Cancer Center. “Access to more diverse
patient-reported health data will help us learn more about long-term aftereffects of cancer
treatments and provide us with a better understanding of the breast cancer patient experience.”
“When it comes to researching how we can better diagnose and prevent disease, numbers are
everything. By using Apple’s new ResearchKit framework, we’re able to extend participation
beyond our local community and capture significantly more data to help us understand how
asthma works,” said Eric Schadt, PhD, the Jean C. and James W. Crystal Professor of Genomics
at the Icahn School of Medicine at Mount Sinai, and Founding Director of the Icahn Institute for
Genomics and Multiscale Biology. “Using iPhone’s advanced sensors, we’re able to better model
an asthma patient’s condition to enable us to deliver a more personalized, more precise
treatment.”
Developed by the Icahn School of Medicine at Mount Sinai and LifeMap Solutions, the Asthma
Health app is designed to facilitate asthma patient education and self-monitoring, promote
positive behavioral changes and reinforce adherence to treatment plans according to current
asthma guidelines. The study tracks symptom patterns in an individual and potential triggers for
these exacerbations so that researchers can learn new ways to personalize asthma treatment.
The Share the Journey app, developed by the Dana-Farber Cancer Institute, Penn Medicine, Sage
Bionetworks and UCLA’s Jonsson Comprehensive Cancer Center, is a research study that aims
to understand why some breast cancer survivors recover faster than others, why their symptoms
vary over time and what can be done to improve symptoms. Share the Journey will use surveys
and sensor data on iPhone to collect and track fatigue, mood and cognitive changes, sleep
disturbances and reduction in exercise.
Developed by Stanford Medicine, the MyHeart Counts app measures activity and uses risk factor
and survey information to help researchers more accurately evaluate how a participant’s activity
and lifestyle relate to cardiovascular health. By studying these relationships on a broad scale,
researchers will be able to understand better how to keep hearts healthier.
Massachusetts General Hospital developed the GlucoSuccess app to understand how various
aspects of a person’s life—diet, physical activity and medications—affect blood glucose levels.
The app can also help participants identify how their food choices and activity relate to their best
glucose levels, enabling them to clearly see correlations and take more active roles in their own
well-being.
Developed by Sage Bionetworks and the University of Rochester, the Parkinson mPower app
helps people living with Parkinson’s disease track their symptoms by recording activities using
sensors in iPhone. These activities include a memory game, finger tapping, speaking and
walking. Activity and survey data from your phone are combined with data from many other
participants to fuel Parkinson’s research at a scale never before possible, making this the world’s
largest and most comprehensive study of this disease.

News
FDA Approves CPR Devices That May Increase
Chance of Surviving Cardiac Arrest
March 9, 2015
The U.S. Food and Drug Administration approved the ResQCPR
System, a system of two devices for first responders to use while
performing cardiopulmonary resuscitation (CPR) on people whose
hearts stop beating (cardiac arrest). The devices may improve the
patient’s chances of surviving cardiac arrest.
The Centers for Disease Control and Prevention estimates that
approximately 300,000 Americans experience an out-of-hospital
cardiac arrest each year. CPR is an emergency procedure that can be
life-saving for people in cardiac arrest. During this procedure,
rescuers manually compress the patient’s chest and manually ventilate the lungs to keep blood
oxygenated and circulating until the heart and breathing restart—or until the rescuers can apply
advanced life-saving techniques, such as defibrillation. If provided immediately after cardiac
arrest, this standard CPR procedure increases a patient’s chance of survival.
The ResQCPR System consists of two devices that are intended to be used together to assist in
performing CPR on adult patients with out-of-hospital, non-traumatic cardiac arrest. The first
device, the ResQPump Active Compression Decompression CPR Device, has a double-grip
handle that attaches to the patient’s chest with a suction cup, allowing the rescuer to push to
deliver compressions and lift for decompressions, which is different than standard CPR. It also
includes a pressure gauge to help rescuers maintain recommended compression depth and a
timing mechanism to help the rescuer maintain the necessary compression rate.
The second device, the ResQPod 16.0 Impedance Threshold Device, fits onto a rescue face mask
or breathing tube. When placed on the patient, it impedes airflow into the chest during chest
decompression with the ResQPump, reducing the pressure inside the patient’s chest and drawing
more blood back to the heart, a concept known as preloading. A greater volume of blood being
drawn into the heart can mean a greater volume of blood flowing out of the heart during the next
compression which may improve overall blood circulation as compared to standard CPR. When
used together, the two devices may increase the amount of oxygenated blood circulated through
a patient’s body during CPR.
“Most people who suffer cardiac arrest outside of a hospital die,” said William Maisel, M.D.,
M.P.H., acting director of the Office of Device Evaluation in the FDA’s Center for Devices and
Radiological Health. “The ResQCPR System may increase oxygenated blood circulation during
CPR, which in turn may improve the likelihood of survival in adult patients with out-of-hospital,
non-traumatic cardiac arrest.”

Centers for Medicare and Medicaid Services
(CMS) CISO Security & Privacy Forum
April 7, 2015: Woodlawn, MD
Event
The CISO Security & Privacy Forum is
hosted by the Information Security Privacy
Group (ISPG) at CMS. The Vision for
ISPG is to provide leadership to CMS in
managing information security and privacy
risks appropriate for evolving cyber
threats. The Mission is to enable the safe use
of sensitive and privacy data while servicing
the healthcare needs of the nation.
The format for this event will include briefings from government and industry. Our featured
speaker is from the Interagency OPSEC Support Staff and will present on “TRASHINT:
Dumpster Diving,” a very popular topic which teaches attendees how one person's trash can be
another person's treasure. We are currently seeking presenters on Identity Theft and Cloud
Security.
Table top displays from prime contractors and small businesses will be a highlight for
information exchange and networking.
Each Marketing Service Package Includes:
Pre-event promotional activity by FBC including postcards, posters and table tents placed
throughout agency
All-hands agency email to go out to CMS personnel from event host
Customizable email template provided to invite current contacts
Event Day:
Admission for 2 company reps at the expo and training sessions
Company description and contact info distributed to each attendee in the Exhibitor Guide
Increased brand awareness through face-to-face interaction with agency attendees
6’ table, 2 chairs and standard electricity
Continental breakfast and lunch will be provided
Centers for Medicare and Medicaid Services Auditorium
Woodlawn, MD
For more information, visit: https://www.fbcinc.com

Armor V2®
PREFERRED
BY THE
MILITARY
BP6:33®
MIL-­‐DTL-­‐46100E
MIL-­‐DTL-­‐12560K
www.astralloy.com
Toll-­‐free: 1.866.587.6970
AUSA Member
MADE IN U.S.A.

HIMSS15 Annual Conference & Exhibition
April 12-16, 2015: Chicago, IL
Event
The 2015 Annual HIMSS Conference
& Exhibition, April 12-16 in Chicago,
is the one must-attend event in the
healthcare IT industry. HIMSS15
brings together 38,000+ healthcare IT
professionals, clinicians, executives
and vendors from around the world.
Exceptional education, world-class
speakers, cutting-edge health IT products and powerful networking are hallmarks of this
industry-leading conference. More than 300 education programs feature keynotes, thought leader
sessions, roundtable discussions and e-sessions, plus preconference symposia and workshops.
No matter where you are in your career—a manager or director looking to optimize and
maximize, a senior-level professional in need of new ideas, or just starting out—HIMSS15 has a
track record of delivering the best cutting-edge education, pioneering health IT products services
and solutions and opportunities to meet industry leaders and expand your network.
This year’s conference is set to offer even more value. George W. Bush headlines a prominent
panel of keynote speakers, including Alexander Gourlay and Bruce Broussard. Favorite exhibits
such as the Connected Patient Gallery and the Federal Health IT Pavilion will make a
reappearance, but various new education and networking sessions have been added to the
program. These novel additions include miss must-see locations like Big Data, Mobile Health
Knowledge Center and Cybersecurity Command Center in the exhibit halls.
McCormick Place Convention Center
2301 S Martin Luther King Drive
Chicago, IL 60616
For more information, visit: http://www.himssconference.org/

PROUDLY MADE IN THE USA
Monticello, Minnesota
800.922.4138
www.electromn.com

Event
April 14-17, 2015: Atlanta, GA
2015 Preparedness Summit
In an increasingly interconnected world,
public health threats can emerge on the other
side of the globe and arrive within a day on
the doorstep of health departments, healthcare
providers, schools, and more. Global health
security preparedness issues such as protecting
against infectious disease, the health effects of
climate change and extreme weather, and
cybersecurity threats to critical infrastructure,
impact all levels of governmental public health and healthcare agencies. The Preparedness
Summit is the premier national conference in the field of public health and healthcare
preparedness and one of the only cross-disciplinary learning opportunities to address issues such
as global health security.
The Preparedness Summit is the first and longest running national conference on public health
preparedness. Since its beginning in 2006, the National Association of County and City Health
Officials (NACCHO) has taken a leadership role in convening a wide array of partners to
participate in the Summit; presenting new research findings, sharing tools and resources, and
providing a variety of opportunities for attendees to learn how to implement model practices that
enhance the nation’s capabilities to prepare for, respond to, and recover from disasters and other
emergencies. Last year, this 4-day annual event brought over 1,600 attendees to Atlanta, Georgia
from nearly every state in the nation as well as several territories and countries, including China
and Australia.
In 2015, the Summit returns to the Atlanta Marriott Marquis from April 14-17 and we hope you
will join us! The largest event of its kind, the 2015 Preparedness Summit will attract nearly 1,800
attendees who work all levels of government (local, state, and federal), emergency management,
volunteer organizations, and healthcare coalitions. The 2015 Preparedness Summit also delivers
opportunities to connect with colleagues and share new research. Most importantly, attendees
will learn how to implement model practices that enhance capabilities to prepare for, respond to,
and recover from disasters and emergencies.
Atlanta Marriott Marquis
265 Peachtree Center Avenue NE
Atlanta, GA 30303
For more information, visit: http://preparednesssummit.org/

Get your free sample
DisCide Ultra
Fax request to 203-377-8988,
email request to customerservice@palmerohealth.com or
Mail to PHC 120 Goodwin Pl Stfd. CT. 06615
Name:__________________________________________________
Street:__________________________________________________
City:______________________State:______Zip Code:___________
PROMO CODE: _______________
(EPA #) hint find on EPA website
As shown on the EPA’s list, Palmero Health Care’s
DisCide Ultra Disinfecting Towelettes and DisCide
Ultra Disinfecting Spray ACHIEVED the Agency’s
stringent efficacy performance standards against
Staphylococcus aureus, Pseudomonas aeruginosa,
and Mycobacterium BCG (tuberculosis bacteria)
and are confirmed as an efficacious hospital disinfectants.
HOW DID YOUR DISINFECTANT RATE?
Visit EPA website for more info
http;//www.epa.gov/oppad001/atp-product-list.pdf
Registered
The Disinfectant
you can trust!
GSA #V797P-2262D
NAICS 339110
Quart with
sprayer
Gallon refill
160 count,
6" x 6¾" towelettes
60 count
10.5 X 10.5
www.palmerohealth.com
USA
MADE IN THE
Vacuum Shock and Vacuum Clean
Vacuum Line Cleaning System
Palmero’s 2-step Vacuum Shock and Vacuum Clean
system can keep vacuum lines functioning at
peak efficiency.
Ease of Use:
Manufacturer Description: Vacuum Shock, the first stage in the
Palmero 2-step system, keeps vacuum lines clean with a single
time-released tablet every 3 months. Maintenance with Vacuum
Clean, the second stage in the system, requires only one selfactivating
tablet per week, each of which releases powerful
cleaning chemicals throughout the week.
Odor Elimination:
Manufacturer Description: Vacuum Shock keeps vacuum lines
free of odor causing bacteria. The neutral pH of the Vacuum
Clean tablets helps to reduce dispersal of amalgam into sewer
systems.
Effectiveness:
Manufacturer Description: Vacuum Shock and Vacuum Clean
provide consistent suction and asepsis while extending pump
life. Vacuum Shock keeps vacuum lines clean while Vacuum
Clean restores pressure and maintains cleanliness.
(6 Tablets) (45 Tablets)
Available in Kits:
E-Vac System Kit:
Jar of shock, Jar of Clean
Shock, Clean Kit:
Jar of shock, Jar of Clean
and 1 Pour & Clean bottle
Operatory Kit:
16 Clean Tablets
and 1 Shock Tablet
NAICS 339110
For more information contact us
www.palmerohealth.com
800-344-6424
Shock & Clean Trial Kit:
16 Clean & 1 Shock
GSA #V797P-2262D

Military and Government Electronic Health
Records & Health Data Interoperability
Symposium
April 28-29, 2015: Arlington, VA
Event
As part of the Omnibus Appropriations Bill, the
Federal Government has set goals for the
Department of Defense and the U.S.
Department of Veterans Affairs around the
former’s Electronic Health Record selection
process and its work with the latter to achieve
interagency interoperability with the VistA
EHR.
This unique symposium will provide attendees with critical and timely information on the latest
advancements in government and military EHR interoperability, analytics, mobility, and patient
privacy technologies that every health care professional must know.
The event features over 25 leading health care experts from OUSD(AT&L)/DoD,
DVA/VBA/VHA, VA/VLER, Gov/VA, DHHS, DoD/OT&E, ONC/DHHS, ARNG,
USA/OTSG, Allscripts, Kaiser Permanente, PwC, KPMG, Walter Reed NMMC, Yale New-
Haven HS, Stanford Medical Center, SAMHSA/CSAT, CSC, Oracle, HP, IHS, eHI, MAeHC,
and OSEHRA presenting:
Emerging EHR & Health Data Interoperability IT Needs and Initiatives & Opportunities
Department of Veterans Affairs & DoD Updates for AHLTA & VistA
Information Assurance and Cyber Security Best Practices for Patient Privacy
Exploiting Big Data HIT and Next-Generation EHRs & Mobile Technologies
The Cloud and What You Must Know for a Secure, Virtual Lifetime EHR
Holiday Inn Rosslyn at Key Bridge
1900 North Fort Myer Drive
Arlington, VA 22209
For more information, visit: http://www.militaryelectronichealthcare.com/

Event
VA Healthcare Summit 2015
May 11-13, 2015: Washington, DC
The medical care requirements of our veterans
have evolved due to the influx of military
operations experienced by the United States
throughout the past few decades. While once
daunting, meeting these requirements are now
feasible as a result of the many advancements
across the Veterans Health Administration.
However, facilitating this exceptional level of
care is not without challenges.
VA Healthcare 2015 will bring together strategic leaders and experts within the Veterans Affairs
to share the best practices that have helped successfully implement new technology upgrades,
clinical care advancements, and more precise administrative efficiencies.
We Will Examine Topics Including:
Future of mental healthcare within the VA
Health informatics in the future of VA care
Technology upgrades that will impact the patient experience such as Telehealth, Vista
Evolution and Health Informatics for Mental Health Care
Innovations in women’s specific care
Treating the growing threat of traumatic brain injury
Administrative innovations through enhancing Veterans Benefits Management System
and Veterans Claims Intake Program
New VA leadership structure and how it will transform the future of the VHA
Implementing Lean Six Sigma to improve VA efficiency and productivity
Benefits of Attending:
Receive CME credits for 2015
Hear from 20+ expert speakers leading VA healthcare initiatives across the US
Gain your Lean Six Certification during our Lean Six Sigma Focus Day
Create your own agenda by choosing from our Technology, Clinical Care, and
Administrative Tracks
Kellogg Conference Hotel
800 Florida Avenue NE
Washington, DC 20002
For more information, visit: http://www.veteransaffairshealthcare.com/

NO MSG NO fi llers NO binders NO additives
NO allergens NO gluten NO artifi cial ingredients
NO preservatives NO BHA NO BHT
NO sodium phosphate
NO propyl gallate
LOWER fat
LOWER sodium
Say yes to a better sausage.
At Jones Dairy Farm, we’re dedicated to helping foodservice operations
offer better-tasting, better-made products. All-natural, quality products
like our lower-sodium pork sausage.
Made with 50% less sodium and certified gluten-free, our sausages
are versatile enough to serve all day long and are completely free of,
well, all that other stuff. The same goes for our turkey, chicken and
beef products, too.
U.S. family owned and operated, Jones is also proud to offer
a guaranteed piece count with every order, as well
as peace-of-mind, safety-sealed packaging.
For a FREE sample, contact Bryon Coleman at
bryonc@jonesdairyfarm.com or 920-691-0230 today—
or visit JonesDairyFarmFoodservice.com to learn more.
© 2014 Jones Dairy Farm

Event
May 29-June 2, 2015: Chicago, IL
2015 ASCO Annual Meeting
The American Society of Clinical Oncology
Annual Meeting brings together 30,000
oncology professionals from around the
world. Educational sessions feature worldrenowned
faculty discussing state-of-the-art
treatment modalities, new therapies, and
ongoing controversies in the field. Science
sessions present the latest ground-breaking
research in oral and poster format.
You’ll meet friends and make connections, and bring back new ideas to your practices and
hospitals. Take the time to familiarize yourself with the different opportunities the Annual
Meeting offers. Mark key dates on your calendar, find out about networking opportunities, and
learn about the committees that develop the session content you’ll discover onsite.
The theme for ASCO 2015 is “Illumination and Innovation: Transforming Data into Learning.”
Innovation—the imaginative and creative use of knowledge to transform how we improve the
lives of patients in a sustainable and scalable manner—is the necessary companion to
illumination. The transformation of data into knowledge, and knowledge into learning, enables
us to move our health care delivery and research systems forward. Illumination and innovation
are how the most adaptable will survive in a changing environment. As oncology professionals,
we have always been and always will be at the forefront of creativity and disruptive change; it is
the nature of who we are, and why we endeavor in this most difficult of medical specialties to
illuminate the path forward.
ASCO’s goal is not the accumulation of knowledge for its own sake, but rather the application of
knowledge to patient care. With data as a shared resource, we can accelerate learning from one
another and from our patients, sharing new insights and making faster strides against cancer.
McCormick Place Convention Center
2301 S Martin Luther King Drive
Chicago, IL 60616
For more information, visit: http://am.asco.org/

Chicago, Illinois
Event
Visitor
Getting to Chicago: Chicago’s central location makes it easy for
travelers to get there quickly. Most U.S. residents can drive to the
city in one or two days, and those who prefer to fly can take one
of the 2,900 daily flights to either the O’Hare International
Airport or the Midway International Airport. O’Hare
International Airport, located 17 miles from downtown, is
one of the largest airports in the world. It is one of North
America’s major international gateway airports, flying over 67
million passengers to and from over 200 destinations around the
globe. Midway International Airport is located 10 miles from
downtown Chicago and offers another convenient travel option for
visitors. It is the nation’s premier point-to-point airport, offering valueoriented
leisure and business travel to over 60 destinations.
Both airports offer taxi service to the downtown area and the suburbs. Rates range from $40-50 from
O’Hare and from $30-40 from Midway, although they may vary based on travel time and are subject to
change. The Chicago Transit Authority serves both airports for easy and economical travel between
downtown and Chicago neighborhoods using the “L” train. The 24-hour CTA Blue Line connects
directly to O’Hare and the CTA Orange Line connects directly to Midway. Another option is
GO Airport Express, which provides shared ride services to all downtown/suburban hotels and many
businesses. Pair fares and group discounts are available along with customized reservation portals for
your groups.
Additionally, many major car rental companies
have facilities at the O’Hare and Midway
Airports, including Avis, Alamo, Budget, and
Hertz. Please visit specific rental company
websites for details. Limousine and chauffer
agencies prefer that all customers reserve cars at
least 48 hours in advance, although cars can
occasionally be ordered with a two-hour notice.
Getting Around Chicago:
Taxi: Taxis are plentiful and easy to hail downtown and at the airports, and offer a convenient way to
get around the city. Credit cards are accepted in all cabs by city mandate. It is standard to tip the driver
about 15-20% of the fare, plus $1-2 per bag if the driver helps you with luggage. Please note that all
fares are subject to change.

Get the bench you need
and get it fast.
Ergo-Line
Your work can’t wait. With Pro-Line’s
“In Stock” Program, you can get the
exact modular workbench your
application demands in 5 days or less -
with your choice of work surface, color,
and many accessories and options.
Dimension Next Modular
Workstations
have been synonymous with quality, functionality and unmatched
ergonomic design.
exact accessories you need.
275066
www.industrialworkbenches.com
1proline.com
(800) 739-9067
Pro-Line is a division of the R.W. Hatfield Co., Inc.

Chicago, Illinois
Event
Visitor
Chicago Transit Authority (CTA): The
CTA operates the nation’s second largest
public transportation system—serving the
city of Chicago and 40 neighboring
communities by rail and bus. Pay cash for
single-trip rides or purchase a reloadable
Transit Card or Unlimited Ride Pass for
added savings. For full fare information
and maps, visit the Chicago Transit
Authority website at transitchicago.com.
Visitors may also opt to take one of
Chicago’s eight “L” lines, which connect
the city via above-ground, street-level, and subway trains. They serve 144 rail stations all over town,
making it one of the most efficient and affordable methods of transportation available. Two lines
operate 24 hours a day: the Blue Line, which connects the airport and downtown, and the Red Line,
which offers service between the north and south sides of town. Additionally, more than 100 bus routes
lace the city, with several lines operating 24 hours a day. Exact change is required for cash fare.
Metra Commuter Rail: This train connects outlying suburbs to downtown and is a fast, easy way to
get into the heart of the city. For exact fares and route maps, visit the Metra website at metrarail.com.
Weather in Chicago:
From a spectacular winter wonderland to a
stunning sun-splashed metropolis, you’ll find
four seasons of fun and beauty in Chicago.
Winters in the city come with chilly temps
and numerous opportunities for snowy
adventures. The average annual snowfall is
37 inches, and daily highs average between
30°F and 38°F. Springtime in Chicago means
blooming flowers and a lively lakefront.
Temperatures typically reach the 50s in April
and then the 70s in May. Summers in
Chicago are also warm, with average daytime temperatures around 85°F. Just note that June is typically
the wettest month of the year, so make sure to bring an umbrella. Fall is a beautiful time of year to be in
Chicago as the leaves turn and temperatures start to cool off. October is usually the driest month, and
temperatures gradually drop from the mid-70s to the mid-40s as it gets closer to winter.

Chicago, Illinois
Event
Visitor
Recommendations for a Business Meeting
Dining in Chicago:
Prosecco: This high-end Italian eatery offers
gourmet comfort food from all 20 regions of Italy in
an art-filled room reminiscent of the faded splendor
of Venice. From house-made pastas to classic
seafood dishes, Executive Chef Mark Sparacino
fuses fresh ingredients with Old World recipes to
create his menu of mouthwatering specialties.
Prosecco also offers one of the largest selections of
Italian sparkling wine in the city, making it easy to
find a suitable pairing for your dish, whether it’s the
spinach Gnocchi with Gorgonzola cream or the veal scaloppine with prosciutto di Parma and fresh
mozzarella. Prosecco is open Monday through Friday for lunch and dinner and Saturdays for dinner
only. 710 N Wells St., (312) 951-9500
La Scarola: Find a piece of Italy in Chicago at La Scarola, a cozy Italian restaurant serving up
authentic fare. The eatery offers an extensive menu that features both contemporary and traditional
Italian dishes, including eggplant parmigiana, clams Mondelli, lasagna, and veal Marsala. There is also
a rotating specials menu with a few items that remain a stronghold, including the penne a la vodka with
shrimp and asparagus. Just make sure that you come hungry—La Scarola is known for its heaping
portions—and that you arrive early since the restaurant is often packed. If you have to wait, the
restaurant has a full bar so you can enjoy a cocktail or a glass of wine until you are seated. The La
Scarola is open for dinner seven days a week. 721 W Grand Ave., (312) 243-1740
Girl & the Goat: For a more casual meeting,
head over to the Girl & the Goat, a local hotspot
famous for its innovative small plates. This fun
and funky restaurant is the brainchild and
culinary home of “Top Chef” Season 4 winner
Stephanie Izard, who uses Mediterranean
flavors and local ingredients to create her unique
dishes. While there is goat on the menu
(including goat pizza with tart cherry soffrito),
Izard serves up so much more. The restaurant’s
menu is divided into vegetable, meat, and fish
categories, with a total of 10 shared plates in each section. Though the offerings will change based on

Chicago, Illinois
Event
Visitor
seasonality, you’ll be hard-pressed to find a dish that doesn’t sound delicious. And be sure to indulge in
a dessert—Izard makes all her savory-sweet creations in-house, like frozen corn nougat and
deconstructed Fudgsicles with olive oil gelato. 809 W Randolph St., (312) 492-6262
Quick Bites on a Budget
Lou Malnati's Pizzeria: A popular pie place is
the family-owned and operated Lou Malnati's
Pizzeria, which is famous for its Chicago-style
deep-dish pizzas. Founded by the son of Rudy
Malnati—who was instrumental in developing
the recipe for Chicago-style pizza—the eatery
has become one of the area’s best-known local
line of pizza restaurants. Each pie is made from
scratch using the finest and freshest ingredients,
such as hand-selected California vine-ripened
tomatoes and fresh mozzarella from the same small dairy that has supplied the pizzeria for more than
40 years. The restaurant has also stayed true to the original recipe that was created in 1943, passing it
down from generation to generation, so come experience these authentic Chicago-style pies which are
unmatched in flavor and taste. 1120 N. State St., (312) 725-7777
Off the Clock:
Navy Pier: For a dose of fun after a busy day,
head over to Navy Pier, a 50-acre playground of
museums, restaurants, parks, and attractions.
The iconic 150-foot Ferris wheel offers stunning
vistas of the city and Lake Michigan, as does the
Crystal Gardens, a gorgeous one-acre botanical
garden in a six-story glass atrium. During the
warmer months, you can also take a bike tour of
Chicago or see the city from the water on one of
the many sightseeing boat cruises, all of which
start at Navy Pier. But no matter what time of the year it is, there is always something happening at the
pier. The fall is packed with Oktoberfest celebrations, firework shows, and art fairs, while the winter
includes special events such as Winter WonderFest and Snow Days Chicago, both of which offer rides
and activities ranging from snowboarding to snowshoeing to ice skating. 600 E. Grand Ave., (312) 595-
5282

Our Sole Focus Is
Primary Imaging…
We’re Committed To
Your Needs.
Konica Minolta.
Right Solutions. Right Time.
The healthcare industry is changing
rapidly. At Konica Minolta we understand
your needs and focus on helping you
achieve improved economic value and
added clinical confidence.
Our Primary Imaging Solutions are
the tools you
need, at the
time you need
them most.
Call us at
1-800-934-1034
or visit us on the web:
medical.konicaminolta.us
Phone: 1 (800) 934-1034
Konica Minolta Medical Imaging
Website: medical.konicaminolta.us

Chicago, Illinois
Event
Visitor
The Art Institute of Chicago: Take pleasure in one of the
nation’s finest and largest collections of Impressionist and
Post-Impressionist art at the Art Institute of Chicago. The
encyclopedic art museum encompasses more than 5,000 years
of human expression from cultures around the world with
works of art ranging from European decorative arts to Asian
art to graphic design to American paintings. You can see
pieces by Claude Monet, Henri Matisse, Pierre-Auguste
Renoir, and Henri de Toulouse-Lautrec, as well as numerous
other works by both legendary and lesser-known artists.
Though there are more than 260,000 pieces of art to view,
make sure to explore the architecturally stunning Modern
Wing, which holds an impressive assortment of modern and
contemporary art, including paintings by Pablo Picasso and original renderings by Frank Lloyd Wright.
111 S. Michigan Ave., (312) 443-3600
After 5 PM: For a night out on the town, head to one of the many wine bars, cocktail lounges, taverns,
or dance clubs. The Wrigleyville area in Lakeview is always bustling, as is nearby Boystown. The
main intersection of North, Milwaukee, and Damen Avenues in Wicker Park is also filled with trendy
destination hotspots, such as the Double Door and the Violet Hour. For some laughs, head to the North
Side neighborhoods, which have a mix of comedy clubs, including Zanies and the famed Second City
in Old Town.
Per Diem Rates as of March 2015:
The following rates apply for Chicago, Illinois
Primary
Destination*
County
Max Lodging by Month
(Excludes Taxes)
Meals & Inc. Exp.
**
Chicago
Cook / Lake
Mar Apr May Jun
159 159 192 192
71
* NOTE: Traveler reimbursement is based on the location of the work activities and not the accommodations, unless lodging is not
available at the work activity, then the agency may authorize the rate where lodging is obtained.
** Meals and Incidental Expenses, see Breakdown of M&IE Expenses for important information on first and last days of travel.

Your Dedicated
Mobile Imaging
Partner
GSA vendor number
GS-30F-0005Y
AS A NATIONAL LEADER IN SHORT-TERM AND LONG-TERM MOBILE IMAGING
SOLUTIONS, WE PROVIDE CUSTOMIZED OPTIONS FOR OUR GSA CLIENTS.
OUR SERVICES INCLUDE:
• Mobile MRI
• Operations management, including staffing, scheduling and marketing
• Asset management, including maintenance, quality control programs and utilization
Trust us to provide you with the expertise, equipment and services you need, when you need it.
Contact us today at 888.643.5007 or Sales@InsightHealth.com.
myCDI.com/Insight/Mobile
Accredited by The Joint Commission